Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)2 passages
• 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.1 passage
• 1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study.1 passage
• 1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.1 passage
• 1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.1 passage
• 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.1 passage
• 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.1 passage
• 1-year risk-adjusted mortality and costs of percutaneous coronary intervention in the Veterans Health Administration: insights from the VA CART Program.1 passage
• 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.1 passage
• 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).1 passage
• 10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.1 passage
• 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction.1 passage
• 10-Year Heart Failure Outcomes From Nurse-Driven Clinics in Rural Sub-Saharan Africa.1 passage
• 10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial.1 passage
• 10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.1 passage
• 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.1 passage
• 10-Year Resource Utilization and Costs for Cardiovascular Care.1 passage
• 10-Year Risk Equations for Incident Heart Failure in the General Population.1 passage
• 10-Year Survival After FFR-Guided Strategy in Isolated Proximal Left Anterior Descending Coronary Stenosis.1 passage
• 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.1 passage
• 2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates.1 passage
• 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.1 passage
• 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques.1 passage
• 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.1 passage
• 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.1 passage
• 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.1 passage
• 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).1 passage
• 2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers.1 passage
• 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion).1 passage
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.1 passage
• 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force.1 passage
• 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.1 passage
• 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiología Intervencionista; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.1 passage
• 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs): Introduction.1 passage
• 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.1 passage
• 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.1 passage
• 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.1 passage
• 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.1 passage
• 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.1 passage
• 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.1 passage
• 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.1 passage
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.1 passage
• 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.1 passage
• 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.1 passage
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.1 passage
• 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2017 Roadmap for Innovation-ACC Health Policy Statement on Healthcare Transformation in the Era of Digital Health, Big Data, and Precision Health: A Report of the American College of Cardiology Task Force on Health Policy Statements and Systems of Care.1 passage
• 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.1 passage
• 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.1 passage
• 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.1 passage
• 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.1 passage
• 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.1 passage
• 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons.1 passage
• 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee.1 passage
• 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) and the American Society of Echocardiography.1 passage
• 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization).1 passage
• 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report.1 passage
• 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).1 passage
• 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee.1 passage
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.1 passage
• 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• 21-Year Survival of Left Internal Mammary Artery-Radial Artery-Y Graft.1 passage
• 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.1 passage
• 3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry.1 passage
• 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.1 passage
• 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.1 passage
• 4-Step Protocol for Disparities in STEMI Care and Outcomes in Women.1 passage
• 40-Year Follow-Up After the Fontan Operation: Long-Term Outcomes of 1,052 Patients.1 passage
• 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.1 passage
• 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.1 passage
• 52 Genetic Loci Influencing Myocardial Mass.1 passage
• 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.1 passage
• 6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation.1 passage
• A 1-h Combination Algorithm Allows Fast Rule-Out and Rule-In of Major Adverse Cardiac Events.1 passage
• A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury.1 passage
• A Case-Control Study of Risk Markers and Mortality in Takotsubo Stress Cardiomyopathy.1 passage
• A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.1 passage
• A Clinician's Guide for Trending Cardiovascular Nutrition Controversies: Part II.1 passage
• A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still.1 passage
• A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty Program.1 passage
• A Contemporary Picture of Enterococcal Endocarditis.1 passage
• A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.1 passage
• A New Educational Framework to Improve Lifelong Learning for Cardiologists.1 passage
• A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.1 passage
• A New Index for Pre-Operative Cardiovascular Evaluation.1 passage
• A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion.1 passage
• A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.1 passage
• A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.1 passage
• A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week.1 passage
• A Pesco-Mediterranean Diet With Intermittent Fasting: JACC Review Topic of the Week.1 passage
• A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.1 passage
• A Population-Based Registry of Patients With Inherited Cardiac Conditions and Resuscitated Cardiac Arrest.1 passage
• A Proposal to Incorporate Trial Data Into a Hybrid American College of Cardiology/American Heart Association Algorithm for the Allocation of Statin Therapy in Primary Prevention.1 passage
• A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.1 passage
• A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.1 passage
• A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.1 passage
• A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.1 passage
• A Test in Context: D-Dimer.1 passage
• A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure.1 passage
• A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations.1 passage
• A Test in Context: Hemoglobin A1 passage
• A Test in Context: High-Sensitivity C-Reactive Protein.1 passage
• A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings.1 passage
• A Test in Context: Lipid Profile, Fasting Versus Nonfasting.1 passage
• A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.1 passage
• A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography.1 passage
• A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.1 passage
• A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.1 passage
• A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis.1 passage
• A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.1 passage
• A moment of reflection on the past and future of the Association of Black Cardiologists: the history, legacy, and relevance of a socially conscious organization dedicated to cardiovascular health equity.1 passage
• A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.1 passage
• A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.1 passage
• ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee.1 passage
• ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomo1 passage
• ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and1 passage
• ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, an1 passage
• ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomograph1 passage
• ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angio1 passage
• ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison.1 passage
• ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.1 passage
• ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison.1 passage
• ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison.1 passage
• ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison.1 passage
• ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and In1 passage
• ACC/AHA/HRS Versus ESC Guidelines for the Diagnosis and Management of Syncope: JACC Guideline Comparison.1 passage
• ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.1 passage
• ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.1 passage
• ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.1 passage
• AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.1 passage
• AHA/ACC vs ESC Guidelines for Management of Adults With Congenital Heart Disease: JACC Guideline Comparison.1 passage
• AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.1 passage
• ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.1 passage
• ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology.1 passage
• Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.1 passage
• Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.1 passage
• Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.1 passage
• Abnormal Extracardiac Development in Fetuses With Congenital Heart Disease.1 passage
• Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes.1 passage
• Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.1 passage
• Absolute Coronary Blood Flow Measured by Continuous Thermodilution in Patients With Ischemia and Nonobstructive Disease.1 passage
• Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.1 passage
• Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.1 passage
• Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses.1 passage
• Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.1 passage
• Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.1 passage
• Achievements and Limitations of Evidence-Based Medicine.1 passage
• Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?1 passage
• Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.1 passage
• Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review.1 passage
• Acute Cardiac Effects of Severe Pre-Eclampsia.1 passage
• Acute Ischemic Stroke Intervention.1 passage
• Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair.1 passage
• Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.1 passage
• Acute Limited Intimal Tears of the Thoracic Aorta.1 passage
• Acute Metabolic Influences on the Natriuretic Peptide System in Humans.1 passage
• Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock.1 passage
• Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit.1 passage
• Acute Pulmonary Embolism: With an Emphasis on an Interventional Approach.1 passage
• Acute Stroke During Pregnancy and Puerperium.1 passage
• Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.1 passage
• Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.1 passage
• Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.1 passage
• Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.1 passage
• Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.1 passage
• Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population.1 passage
• Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review.1 passage
• Advanced Management of Intermediate- and High-Risk Pulmonary Embolism: JACC Focus Seminar.1 passage
• Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review.1 passage
• Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.1 passage
• Advances in the Genetics of Congenital Heart Disease: A Clinician's Guide.1 passage
• Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.1 passage
• Adverse Events Due to Transcatheter Pulmonary Valve Replacement: We Are Being too Hard on Ourselves.1 passage
• Adverse Events, Radiation Exposure, and Reinterventions Following Transcatheter Pulmonary Valve Replacement.1 passage
• Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.1 passage
• Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.1 passage
• Age-Related Variations in Takotsubo Syndrome.1 passage
• Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio.1 passage
• Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Alcohol Abuse and Cardiac Disease.1 passage
• Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Balance.1 passage
• Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Endorsement.1 passage
• Alcohol and Atrial Fibrillation: A Sobering Review.1 passage
• Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.1 passage
• Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.1 passage
• Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.1 passage
• Alteration of Cardiac Performance and Serum B-Type Natriuretic Peptide Level in Healthy Aging.1 passage
• Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients.1 passage
• Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion.1 passage
• Alzheimer's Disease and Vascular Aging: JACC Focus Seminar.1 passage
• Ambient Air Pollution and Mortality After Cardiac Transplantation.1 passage
• Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.1 passage
• Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.1 passage
• Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement.1 passage
• Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.1 passage
• Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review.1 passage
• Angioscopic Evaluation of Spontaneously Ruptured Aortic Plaques.1 passage
• Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.1 passage
• Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.1 passage
• Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.1 passage
• Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?1 passage
• Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.1 passage
• Anomalous Aortic Origin of a Coronary Artery From the Inappropriate Sinus of Valsalva.1 passage
• Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.1 passage
• Anterior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement.1 passage
• Anterior T-Wave Inversion in Young White Athletes and Nonathletes: Prevalence and Significance.1 passage
• Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.1 passage
• Antibiotic Prophylaxis and Incidence of Endocarditis Before and After the 2007 AHA Recommendations.1 passage
• Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement.1 passage
• Anticoagulation During Pregnancy: Evolving Strategies With a Focus on Mechanical Valves.1 passage
• Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.1 passage
• Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass.1 passage
• Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.1 passage
• Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.1 passage
• Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.1 passage
• Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics.1 passage
• Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.1 passage
• Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar.1 passage
• Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.1 passage
• Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus.1 passage
• Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances.1 passage
• Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice.1 passage
• Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.1 passage
• Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5).1 passage
• Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration.1 passage
• Aortic Branch Aneurysms and Vascular Risk in Patients With Marfan Syndrome.1 passage
• Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.1 passage
• Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.1 passage
• Aortic Valve Replacement and the Ross Operation in Children and Young Adults.1 passage
• Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis Outside Randomized Trials.1 passage
• Aortic Valve Sparing in Different Aortic Valve and Aortic Root Conditions.1 passage
• Aortic Valve Stenosis Treatment Disparities in the Underserved: JACC Council Perspectives.1 passage
• Aortic stenosis and perioperative risk with noncardiac surgery.1 passage
• Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.1 passage
• Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.1 passage
• Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.1 passage
• Are All Total Occlusions Created Equal?: Striving for Complete Revascularization While Differentiating Apples From Oranges.1 passage
• Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?1 passage
• Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.1 passage
• Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.1 passage
• Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.1 passage
• Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes.1 passage
• Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week.1 passage
• Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.1 passage
• Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.1 passage
• Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.1 passage
• Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.1 passage
• Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.1 passage
• Arterial Thrombus Stability: Does It Matter and Can We Detect It?1 passage
• Artificial Intelligence in Cardiology.1 passage
• Artificial Intelligence in Cardiovascular Imaging: JACC State-of-the-Art Review.1 passage
• Artificial Intelligence in Precision Cardiovascular Medicine.1 passage
• Artificial Lungs for Lung Failure: JACC Technology Corner.1 passage
• Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected Dimension.1 passage
• Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.1 passage
• Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.1 passage
• Aspirin and Cancer.1 passage
• Aspirin for Primary Prevention of Cardiovascular Events.1 passage
• Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.1 passage
• Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the Week.1 passage
• Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.1 passage
• Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome.1 passage
• Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.1 passage
• Association Between Alcohol Intake and Cardiac Remodeling.1 passage
• Association Between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study.1 passage
• Association Between Left Ventricular Noncompaction and Vigorous Physical Activity.1 passage
• Association Between Presence of a Cardiac Intensivist and Mortality in an Adult Cardiac Care Unit.1 passage
• Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.1 passage
• Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis.1 passage
• Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction.1 passage
• Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.1 passage
• Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality.1 passage
• Association of Assisted Reproductive Technologies With Arterial Hypertension During Adolescence.1 passage
• Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation.1 passage
• Association of Bioprosthetic Aortic Valve Leaflet Calcification on Hemodynamic and Clinical Outcomes.1 passage
• Association of Cardiovascular Disease With Respiratory Disease.1 passage
• Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.1 passage
• Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.1 passage
• Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.1 passage
• Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA).1 passage
• Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study.1 passage
• Association of Family History With Incidence and Outcomes of Aortic Dissection.1 passage
• Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.1 passage
• Association of Guideline-Based Admission Treatments and Life Expectancy After Myocardial Infarction in Elderly Medicare Beneficiaries.1 passage
• Association of Hypertensive Disorders of Pregnancy With Left Ventricular Remodeling Later in Life.1 passage
• Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI.1 passage
• Association of Microvesicles With Graft Patency in Patients Undergoing CABG Surgery.1 passage
• Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients.1 passage
• Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.1 passage
• Association of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease.1 passage
• Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction.1 passage
• Association of Skipping Breakfast With Cardiovascular and All-Cause Mortality.1 passage
• Association of Sleep Duration and Quality With Subclinical Atherosclerosis.1 passage
• Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.1 passage
• Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.1 passage
• Association of TSR1 Variants and Spontaneous Coronary Artery Dissection.1 passage
• Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.1 passage
• Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification.1 passage
• Association of Variants Near the Bradykinin Receptor B1 passage
• Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.1 passage
• Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention.1 passage
• Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection.1 passage
• Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline.1 passage
• Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.1 passage
• Associations of Body Mass and Fat Indexes With Cardiometabolic Traits.1 passage
• Associations of Late Adolescent or Young Adult Cardiovascular Health With Premature Cardiovascular Disease and Mortality.1 passage
• Associations of Race and Ethnicity With Presentation and Outcomes of Hypertrophic Cardiomyopathy: JACC Focus Seminar 6/9.1 passage
• Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.1 passage
• Atherosclerotic Cardiovascular Disease Risk Stratification Based on Measurements of Troponin and Coronary Artery Calcium.1 passage
• Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events.1 passage
• Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease.1 passage
• Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.1 passage
• Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.1 passage
• Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad?1 passage
• Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.1 passage
• Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.1 passage
• Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.1 passage
• Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.1 passage
• Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.1 passage
• Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.1 passage
• Atrial Fibrillation: JACC Council Perspectives.1 passage
• Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.1 passage
• Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.1 passage
• Atrioventricular Valve Failure in Fontan Palliation.1 passage
• Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.1 passage
• Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.1 passage
• Automated Prediction of Cardiorespiratory Deterioration in Patients With Single Ventricle.1 passage
• Autonomic Nervous System Dysfunction: JACC Focus Seminar.1 passage
• Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1.1 passage
• Autoregulation of Coronary Blood Supply in Response to Demand: JACC Review Topic of the Week.1 passage
• Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis.1 passage
• Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.1 passage
• Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.1 passage
• B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.1 passage
• B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.1 passage
• Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation: Population-Based, Self-Controlled Series.1 passage
• Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects.1 passage
• Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.1 passage
• Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.1 passage
• Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 1/4: JACC Focus Seminar.1 passage
• Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series.1 passage
• Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.1 passage
• Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial.1 passage
• Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.1 passage
• Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.1 passage
• Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.1 passage
• Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.1 passage
• Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy.1 passage
• Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement.1 passage
• Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.1 passage
• Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial.1 passage
• Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study.1 passage
• Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.1 passage
• Biological Versus Chronological Aging: JACC Focus Seminar.1 passage
• Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.1 passage
• Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.1 passage
• Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.1 passage
• Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.1 passage
• Bioprosthetic Total Artificial Heart Induces a Profile of Acquired Hemocompatibility With Membranes Recellularization.1 passage
• Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors.1 passage
• Bioprosthetic Valve Thrombosis.1 passage
• Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.1 passage
• Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.1 passage
• Bioresorbable vascular scaffolds in daily clinical practice: is the essential really invisible to the eyes?1 passage
• Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.1 passage
• Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.1 passage
• Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.1 passage
• Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.1 passage
• Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.1 passage
• Bleeding avoidance strategies during percutaneous coronary interventions.1 passage
• Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.1 passage
• Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.1 passage
• Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization.1 passage
• Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.1 passage
• Blood Pressure Management in Afferent Baroreflex Failure: JACC Review Topic of the Week.1 passage
• Blood Pressure Variation and Subclinical Brain Disease.1 passage
• Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.1 passage
• Brain Injury After Transcatheter Replacement of Bicuspid Versus Tricuspid Aortic Valves.1 passage
• Bridging Anticoagulation: Primum Non Nocere.1 passage
• Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.1 passage
• Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya.1 passage
• Building trust for the safety of the patient: from internship to fellowship.1 passage
• Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.1 passage
• Burden of Readmissions Among Patients With Critical Limb Ischemia.1 passage
• Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.1 passage
• CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.1 passage
• CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis.1 passage
• COCATS 4: Securing the Future of Cardiovascular Medicine.1 passage
• COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week.1 passage
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.1 passage
• COVID-19 in Adults With Congenital Heart Disease.1 passage
• COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.1 passage
• CPR Instruction in U.S. High Schools: What Is the State in the Nation?1 passage
• Calcification in Aortic Stenosis: The Skeleton Key.1 passage
• Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.1 passage
• Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital.1 passage
• Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.1 passage
• Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.1 passage
• Cardiac Arrest: A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose Patient.1 passage
• Cardiac Arrhythmias in Africa: Epidemiology, Management Challenges, and Perspectives.1 passage
• Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up.1 passage
• Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.1 passage
• Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.1 passage
• Cardiac Evaluation of Children With a Family History of Sudden Death.1 passage
• Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.1 passage
• Cardiac Genetic Predisposition in Sudden Infant Death Syndrome.1 passage
• Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems.1 passage
• Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.1 passage
• Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study.1 passage
• Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.1 passage
• Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain.1 passage
• Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.1 passage
• Cardiac Pacing Training in Africa: Endorsed by the Africa Heart Rhythm Association (AFHRA): JACC International.1 passage
• Cardiac Pacing in Sub-Saharan Africa: JACC International.1 passage
• Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review.1 passage
• Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.1 passage
• Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.1 passage
• Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.1 passage
• Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.1 passage
• Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block.1 passage
• Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study.1 passage
• Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.1 passage
• Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria.1 passage
• Cardiac Sarcoidosis.1 passage
• Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.1 passage
• Cardiac Shock Care Centers: JACC Review Topic of the Week.1 passage
• Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.1 passage
• Cardiac Troponin Elevation in Patients Without a Specific Diagnosis.1 passage
• Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.1 passage
• Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week.1 passage
• Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review.1 passage
• Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate".1 passage
• Cardiac risk of noncardiac surgery.1 passage
• Cardio-Oncology Education and Training: JACC Council Perspectives.1 passage
• Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach.1 passage
• Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.1 passage
• Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.1 passage
• Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.1 passage
• Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload.1 passage
• Cardiopulmonary Exercise Testing: What Is its Value?1 passage
• Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.1 passage
• Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review.1 passage
• Cardiopulmonary benefits of reducing indoor particles of outdoor origin: a randomized, double-blind crossover trial of air purifiers.1 passage
• Cardiorespiratory Fitness and Mortality in Healthy Men and Women.1 passage
• Cardiorespiratory Fitness in Middle Age and Health Care Costs in Later Life.1 passage
• Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week.1 passage
• Cardiovascular Aging and Longevity: JACC State-of-the-Art Review.1 passage
• Cardiovascular Benefits of Fish-Oil Supplementation Against Fine Particulate Air Pollution in China.1 passage
• Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.1 passage
• Cardiovascular Care for Pregnant Women With Cardiovascular Disease.1 passage
• Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.1 passage
• Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.1 passage
• Cardiovascular Complications of Opioid Use: JACC State-of-the-Art Review.1 passage
• Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.1 passage
• Cardiovascular Deaths During the COVID-19 Pandemic in the United States.1 passage
• Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series.1 passage
• Cardiovascular Disease and Homelessness.1 passage
• Cardiovascular Disease in Incarcerated Populations.1 passage
• Cardiovascular Diseases in India Compared With the United States.1 passage
• Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week.1 passage
• Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.1 passage
• Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes.1 passage
• Cardiovascular Effects of the New Weight Loss Agents.1 passage
• Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).1 passage
• Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.1 passage
• Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.1 passage
• Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids: JACC Focus Seminar.1 passage
• Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.1 passage
• Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.1 passage
• Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement.1 passage
• Cardiovascular Medicine and Society: The Pregnant Cardiologist.1 passage
• Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults.1 passage
• Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.1 passage
• Cardiovascular Outcomes Reported in Hemodialysis Trials.1 passage
• Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.1 passage
• Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.1 passage
• Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis.1 passage
• Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.1 passage
• Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.1 passage
• Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.1 passage
• Cardiovascular Therapies Targeting Left Atrial Appendage.1 passage
• Cardiovascular Toxicities Associated With Ibrutinib.1 passage
• Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.1 passage
• Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.1 passage
• Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum: Insights From the UK Biobank.1 passage
• Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.1 passage
• Cardiovascular drug development: is it dead or just hibernating?1 passage
• Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.1 passage
• Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention: A Meta-Analysis of Clinical Trials.1 passage
• Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis: JACC Review Topic of the Week.1 passage
• Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis.1 passage
• Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.1 passage
• Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry.1 passage
• Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy.1 passage
• Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.1 passage
• Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.1 passage
• Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.1 passage
• Catheter ablation of atrial fibrillation: how to modify the substrate?1 passage
• Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.1 passage
• Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX.1 passage
• Causes of Death in Anticoagulated Patients With Atrial Fibrillation.1 passage
• Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.1 passage
• Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life.1 passage
• Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.1 passage
• Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study.1 passage
• Cerebrovascular Events After Cardiovascular Procedures: Risk Factors, Recognition, and Prevention Strategies.1 passage
• Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions: JACC State-of-the-Art Review.1 passage
• Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.1 passage
• Challenges in Infective Endocarditis.1 passage
• Challenges in the Design and Interpretation of Noninferiority Trials: Insights From Recent Stent Trials.1 passage
• Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials.1 passage
• Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.1 passage
• Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.1 passage
• Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.1 passage
• Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial.1 passage
• Changes in the Professional Lives of Cardiologists Over 2 Decades.1 passage
• Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection: Literature Review and Insights.1 passage
• Characteristics of Adults With Congenital Heart Defects in the United States.1 passage
• Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.1 passage
• Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.1 passage
• Characterization of Myocardial Injury in Patients With COVID-19.1 passage
• Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.1 passage
• Child Health Promotion in Underserved Communities: The FAMILIA Trial.1 passage
• Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood.1 passage
• Children Present a Window of Opportunity for Promoting Health: JACC Review Topic of the Week.1 passage
• Chili Pepper Consumption and Mortality in Italian Adults.1 passage
• Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.1 passage
• Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.1 passage
• Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.1 passage
• Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study.1 passage
• Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.1 passage
• Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.1 passage
• Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.1 passage
• Chronic Thromboembolic Pulmonary Hypertension: JACC Focus Seminar.1 passage
• Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease.1 passage
• Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial.1 passage
• Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.1 passage
• Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure.1 passage
• Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases.1 passage
• Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.1 passage
• Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction.1 passage
• Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.1 passage
• Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry.1 passage
• Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.1 passage
• Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.1 passage
• Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.1 passage
• Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies.1 passage
• Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment.1 passage
• Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.1 passage
• Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria.1 passage
• Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.1 passage
• Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.1 passage
• Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community.1 passage
• Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.1 passage
• Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.1 passage
• Clinical Implications of Focal Intimal Disruption in Patients With Type B Intramural Hematoma.1 passage
• Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.1 passage
• Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy.1 passage
• Clinical Outcomes Following the Ross Procedure in Adults: A 25-Year Longitudinal Study.1 passage
• Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study.1 passage
• Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).1 passage
• Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.1 passage
• Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing.1 passage
• Clinical Outcomes of Infective Endocarditis in Injection Drug Users.1 passage
• Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.1 passage
• Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.1 passage
• Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.1 passage
• Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.1 passage
• Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement.1 passage
• Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction.1 passage
• Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.1 passage
• Clinical and Angiographic Features of Patients With Out-of-Hospital Cardiac Arrest and Acute Myocardial Infarction.1 passage
• Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.1 passage
• Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.1 passage
• Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.1 passage
• Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.1 passage
• Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.1 passage
• Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation.1 passage
• Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.1 passage
• Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines.1 passage
• Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.1 passage
• Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.1 passage
• Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.1 passage
• Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.1 passage
• Coenzyme Q1 passage
• Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy.1 passage
• Cognition After Lowering LDL-Cholesterol With Evolocumab.1 passage
• Cognitive Decline Before and After Incident Coronary Events.1 passage
• Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.1 passage
• Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.1 passage
• Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.1 passage
• Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.1 passage
• Community Health Workers Improve Linkage to Hypertension Care in Western Kenya.1 passage
• Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 Trial.1 passage
• Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites.1 passage
• Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.1 passage
• Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.1 passage
• Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.1 passage
• Comparative Trends in Percutaneous Coronary Intervention in Japan and the United States, 2013 to 2017.1 passage
• Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.1 passage
• Comparison of Coronary Computed Tomography Angiography, Fractional Flow Reserve, and Perfusion Imaging for Ischemia Diagnosis.1 passage
• Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.1 passage
• Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal?1 passage
• Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine Therapy.1 passage
• Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot.1 passage
• Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.1 passage
• Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.1 passage
• Complement C5 Protein as a Marker of Subclinical Atherosclerosis.1 passage
• Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.1 passage
• Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.1 passage
• Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation.1 passage
• Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.1 passage
• Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke.1 passage
• Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment.1 passage
• Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial.1 passage
• Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.1 passage
• Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.1 passage
• Comprehensive Metabolomic Characterization of Coronary Artery Diseases.1 passage
• Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome.1 passage
• Compression-Only Versus Rescue-Breathing Cardiopulmonary Resuscitation After Pediatric Out-of-Hospital Cardiac Arrest.1 passage
• Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease.1 passage
• Computer-Interpreted Electrocardiograms: Benefits and Limitations.1 passage
• Concomitant Mitral Regurgitation in Patients With Chronic Aortic Regurgitation.1 passage
• Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.1 passage
• Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel.1 passage
• Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.1 passage
• Congenital Muscular Mitral-Aortic Discontinuity Identified in Patients With Obstructive Hypertrophic Cardiomyopathy.1 passage
• Constrictive Pericarditis Versus Restrictive Cardiomyopathy?1 passage
• Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.1 passage
• Contemporary Management of Severe Symptomatic Aortic Stenosis.1 passage
• Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.1 passage
• Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.1 passage
• Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.1 passage
• Contemporary Outcomes in Patients With Long QT Syndrome.1 passage
• Contemporary Review on Spontaneous Coronary Artery Dissection.1 passage
• Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies: JACC Focus Seminar 3/5.1 passage
• Continuously Updated Estimation of Heart Transplant Waitlist Mortality.1 passage
• Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5.1 passage
• Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography.1 passage
• Contrast-Induced Acute Kidney Injury.1 passage
• Contribution of Gene Regulatory Networks to Heritability of Coronary Artery Disease.1 passage
• Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.1 passage
• Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.1 passage
• Coronary1 passage
• Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina.1 passage
• Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.1 passage
• Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.1 passage
• Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.1 passage
• Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.1 passage
• Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.1 passage
• Coronary Artery Disease in Patients ≥80 Years of Age.1 passage
• Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study.1 passage
• Coronary Artery Target Selection and Survival After Bilateral Internal Thoracic Artery Grafting.1 passage
• Coronary Atheroma Regression From Infusions of Autologous Selectively Delipidated Preβ-HDL-Enriched Plasma in Homozygous Familial Hypercholesterolemia.1 passage
• Coronary Atherosclerotic Precursors of Acute Coronary Syndromes.1 passage
• Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease.1 passage
• Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study.1 passage
• Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.1 passage
• Coronary Calcium Score and Cardiovascular Risk.1 passage
• Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review.1 passage
• Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review.1 passage
• Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis.1 passage
• Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.1 passage
• Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.1 passage
• Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.1 passage
• Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.1 passage
• Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study.1 passage
• Coronary Microvascular Dysfunction in Vasospastic Angina: Provocative Role for the Microcirculation in Macrovessel Disease Prognosis.1 passage
• Coronary Physiology Beyond Coronary Flow Reserve in Microvascular Angina: JACC State-of-the-Art Review.1 passage
• Coronary Physiology During Exercise and Vasodilation in the Healthy Heart and in Severe Aortic Stenosis.1 passage
• Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.1 passage
• Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar.1 passage
• Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.1 passage
• Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar.1 passage
• Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Randomized Controlled Trial.1 passage
• Cost Implications of Using Different ECG Criteria for Screening Young Athletes in the United Kingdom.1 passage
• Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.1 passage
• Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults.1 passage
• Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.1 passage
• Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.1 passage
• Cost-effectiveness of revascularization strategies: the ASCERT study.1 passage
• Costs associated with health care-associated infections in cardiac surgery.1 passage
• Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?1 passage
• Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation.1 passage
• Critical Appraisal of the 2018 ACC Scientific Sessions Late-Breaking Trials From a Statistician's Perspective.1 passage
• Critical Limb Ischemia: An Expert Statement.1 passage
• Critical Questions About Left-Sided Infective Endocarditis.1 passage
• Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.1 passage
• Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.1 passage
• Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.1 passage
• Cryptogenic Stroke and Patent Foramen Ovale.1 passage
• Cumulative Blood Pressure in Early Adulthood and Cardiac Dysfunction in Middle Age: The CARDIA Study.1 passage
• Current Status and Future Prospects of Transcatheter Mitral Valve Replacement: JACC State-of-the-Art Review.1 passage
• Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.1 passage
• Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.1 passage
• DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction.1 passage
• Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.1 passage
• Data Sharing and Cardiology: Platforms and Possibilities.1 passage
• De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.1 passage
• Declining Lung Function and Cardiovascular Risk: The ARIC Study.1 passage
• Deconstructing the Paradox of Smoking and Improved Short-Term Cardiovascular Outcomes After Myocardial Infarction.1 passage
• Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.1 passage
• Defibrillation for Ventricular Fibrillation: A Shocking Update.1 passage
• Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.1 passage
• Delayed Atrioventricular Block Following Transcatheter Aortic Valve Replacement: Risk Stratification or Crystal Ball?1 passage
• Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.1 passage
• Deprescribing in Older Adults With Cardiovascular Disease.1 passage
• Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials.1 passage
• Detection and Prediction of Bioprosthetic Aortic Valve Degeneration.1 passage
• Detection of Atherosclerotic Inflammation by1 passage
• Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram.1 passage
• Determinants and Outcomes of Asymptomatic Intracranial Atherosclerotic Stenosis.1 passage
• Determining When to Add Nonstatin Therapy: A Quantitative Approach.1 passage
• Developing a Mobile Application for Global Cardiovascular Education.1 passage
• Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization.1 passage
• Development of Quality Metrics in Ambulatory Pediatric Cardiology.1 passage
• Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.1 passage
• Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.1 passage
• Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.1 passage
• Device-detected atrial fibrillation: what to do with asymptomatic patients?1 passage
• Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.1 passage
• Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.1 passage
• Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.1 passage
• Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.1 passage
• Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.1 passage
• Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week.1 passage
• Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance.1 passage
• Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.1 passage
• Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis.1 passage
• Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5.1 passage
• Diagnostic Performance of Dynamic Myocardial Perfusion Imaging Using Dual-Source Computed Tomography.1 passage
• Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE.1 passage
• Diagnostic Testing in Coronary Artery Disease: Relieving the Stenosis, Attenuating Ischemia, or Preventing Hard Events?1 passage
• Diagnostic Ultrasound Impulses Improve Microvascular Flow in Patients With STEMI Receiving Intravenous Microbubbles.1 passage
• Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.1 passage
• Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation.1 passage
• Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.1 passage
• Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.1 passage
• Diet-Derived Circulating Antioxidants and Risk of Coronary Heart Disease: A Mendelian Randomization Study.1 passage
• Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S.1 passage
• Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.1 passage
• Dietary sodium and health: more than just blood pressure.1 passage
• Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.1 passage
• Different Lifestyle Interventions in Adults From Underserved Communities: The FAMILIA Trial.1 passage
• Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.1 passage
• Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.1 passage
• Differential Risk of ST-Segment Elevation Myocardial Infarction in Male and Female Smokers.1 passage
• Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics.1 passage
• Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.1 passage
• Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.1 passage
• Digoxin and Mortality in Patients With Atrial Fibrillation.1 passage
• Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.1 passage
• Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction.1 passage
• Direct Catheter-Based Thrombectomy for Acute Ischemic Stroke: Outcomes of Consecutive Patients Treated in Interventional Cardiology Centers in Close Cooperation With Neurologists.1 passage
• Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.1 passage
• Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.1 passage
• Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.1 passage
• Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.1 passage
• Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.1 passage
• Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial.1 passage
• Discordance of High-Sensitivity Troponin Assays in Patients With Suspected Acute Coronary Syndromes.1 passage
• Discordances Between Pre-Natal and Post-Natal Diagnoses of Congenital Heart Diseases and Impact on Care Strategies.1 passage
• Discrepancies in Measurement of the Thoracic Aorta: JACC Review Topic of the Week.1 passage
• Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.1 passage
• Dissemination of Transcatheter Aortic Valve Replacement in the United States.1 passage
• Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.1 passage
• Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.1 passage
• Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.1 passage
• Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis.1 passage
• Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?: A Mediation Model.1 passage
• Does Vascular Calcification Accelerate Inflammation?: A Substudy of the dal-PLAQUE Trial.1 passage
• Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.1 passage
• Dose of jogging and long-term mortality: the Copenhagen City Heart Study.1 passage
• Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.1 passage
• Downstream Cascades of Care Following High-Sensitivity Troponin Test Implementation.1 passage
• Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.1 passage
• Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review.1 passage
• Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.1 passage
• Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.1 passage
• Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.1 passage
• Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.1 passage
• Dual Antiplatelet Therapy Following PCI for NSTEMI: An Obvious Choice or a Calculated Decision?1 passage
• Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.1 passage
• Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.1 passage
• Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.1 passage
• Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.1 passage
• Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.1 passage
• Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence.1 passage
• Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.1 passage
• Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Duration of Pre-Operative Antibiotic Treatment and Culture Results in Patients With Infective Endocarditis.1 passage
• Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.1 passage
• Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.1 passage
• Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.1 passage
• Dystrophin-Deficient Cardiomyopathy.1 passage
• Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.1 passage
• Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I.1 passage
• Early Experience With New Transcatheter Mitral Valve Replacement.1 passage
• Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review.1 passage
• Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results.1 passage
• Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest: A Multicenter, Randomized Controlled Trial.1 passage
• Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.1 passage
• Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.1 passage
• Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.1 passage
• Early and Late Outcomes of Surgical Treatment in Carcinoid Heart Disease.1 passage
• Early-Life Environmental Exposures and Blood Pressure in Children.1 passage
• Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.1 passage
• Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States.1 passage
• Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.1 passage
• Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.1 passage
• Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.1 passage
• Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.1 passage
• Echocardiography-Guided Risk Stratification for Long QT Syndrome.1 passage
• Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.1 passage
• Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.1 passage
• Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.1 passage
• Editor-in-Chief's Picks From 2014: Part One.1 passage
• Editor-in-Chief's Top Picks From 2015: Part One.1 passage
• Editor-in-Chief's Top Picks From 2015: Part Two.1 passage
• Editor-in-Chief's Top Picks From 2016: Part One.1 passage
• Editor-in-Chief's Top Picks From 2016: Part Two.1 passage
• Editor-in-Chief's Top Picks From 2018.1 passage
• Editor-in-Chief's Top Picks From 2020.1 passage
• Editor-in-chief's picks from 2014: part two.1 passage
• Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.1 passage
• Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.1 passage
• Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.1 passage
• Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.1 passage
• Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.1 passage
• Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.1 passage
• Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices.1 passage
• Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion.1 passage
• Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.1 passage
• Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.1 passage
• Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery.1 passage
• Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors.1 passage
• Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.1 passage
• Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.1 passage
• Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.1 passage
• Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization.1 passage
• Effect of Evolocumab on Coronary Plaque Composition.1 passage
• Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.1 passage
• Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome.1 passage
• Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging: The AQUAMARINE Pilot Study.1 passage
• Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.1 passage
• Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.1 passage
• Effect of Plaque Burden and Morphology on Myocardial Blood Flow and Fractional Flow Reserve.1 passage
• Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation.1 passage
• Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes.1 passage
• Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.1 passage
• Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.1 passage
• Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults.1 passage
• Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.1 passage
• Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.1 passage
• Effect of Testosterone on Natriuretic Peptide Levels.1 passage
• Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.1 passage
• Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.1 passage
• Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.1 passage
• Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.1 passage
• Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.1 passage
• Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.1 passage
• Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.1 passage
• Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.1 passage
• Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.1 passage
• Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.1 passage
• Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial.1 passage
• Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.1 passage
• Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.1 passage
• Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.1 passage
• Effects of Large Financial Incentives for Long-Term Smoking Cessation: A Randomized Trial.1 passage
• Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.1 passage
• Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG Trial.1 passage
• Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.1 passage
• Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.1 passage
• Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly.1 passage
• Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.1 passage
• Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study.1 passage
• Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.1 passage
• Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial.1 passage
• Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.1 passage
• Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.1 passage
• Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.1 passage
• Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.1 passage
• Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.1 passage
• Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.1 passage
• Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure.1 passage
• Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.1 passage
• Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.1 passage
• Ejection Fraction Improvement After Primary Prevention Defibrillator Implantation: How Much Is Enough?1 passage
• Ejection Fraction Pros and Cons: JACC State-of-the-Art Review.1 passage
• Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome.1 passage
• Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy.1 passage
• Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.1 passage
• Elevated Lipoprotein(a) and Risk of Ischemic Stroke.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.1 passage
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.1 passage
• Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.1 passage
• Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.1 passage
• Emergency Department Visits by Children With Congenital Heart Disease.1 passage
• Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.1 passage
• Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group.1 passage
• Emerging Techniques for Risk Stratification in Nonischemic Dilated Cardiomyopathy: JACC Review Topic of the Week.1 passage
• Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.1 passage
• Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.1 passage
• Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.1 passage
• Endocarditis After Transcatheter Pulmonary Valve Replacement.1 passage
• Endogenous Fibrinolysis: An Important Mediator of Thrombus Formation and Cardiovascular Risk.1 passage
• Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.1 passage
• Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Endovascular Aortic Repair in Nonagenarian Patients.1 passage
• Endovascular Repair Compared With Medical Management of Patients With Uncomplicated Type B Acute Aortic Dissection.1 passage
• Endovascular Versus Open Repair of Intact Descending Thoracic Aortic Aneurysms.1 passage
• Enhanced Assessment of Perioperative Mortality Risk in Adults With Congenital Heart Disease.1 passage
• Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.1 passage
• Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.1 passage
• Environmental Noise and the Cardiovascular System.1 passage
• Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes.1 passage
• Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality.1 passage
• Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium.1 passage
• Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.1 passage
• Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International.1 passage
• Epigenetic Modification in Coronary Atherosclerosis: JACC Review Topic of the Week.1 passage
• Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.1 passage
• Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death.1 passage
• Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I.1 passage
• Essential Role for Premature Senescence of Myofibroblasts in Myocardial Fibrosis.1 passage
• Estimating Left Ventricular Filling Pressure by Echocardiography.1 passage
• Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.1 passage
• Ethical Dilemmas Associated With the COVID-19 Pandemic: Dealing With the Unknowns and Unanswerables During Training.1 passage
• Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.1 passage
• Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry.1 passage
• Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.1 passage
• Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.1 passage
• Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.1 passage
• Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review.1 passage
• Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).1 passage
• Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.1 passage
• Evaluation of 30-Day Hospital Readmission and Mortality Rates Using Regression-Discontinuity Framework.1 passage
• Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.1 passage
• Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy.1 passage
• Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.1 passage
• Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS).1 passage
• Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.1 passage
• Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.1 passage
• Evolution of the American College of Cardiology/American Heart Association Clinical Guidelines.1 passage
• Evolving therapies for myocardial ischemia/reperfusion injury.1 passage
• Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.1 passage
• Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries.1 passage
• Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.1 passage
• Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.1 passage
• Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort.1 passage
• Exercise Training for Patients With Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.1 passage
• Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.1 passage
• Exercise at the Extremes: The Amount of Exercise to Reduce Cardiovascular Events.1 passage
• Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure.1 passage
• Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.1 passage
• Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis.1 passage
• Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.1 passage
• Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.1 passage
• Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization.1 passage
• External Aortic Root Support to Prevent Aortic Dilatation in Patients With Marfan Syndrome.1 passage
• External Validation of the DAPT Score in a Nationwide Population.1 passage
• External Validation of the SYNTAX Score II 2020.1 passage
• Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.1 passage
• Extracellular Matrix in Vascular Disease, Part 2/4: JACC Focus Seminar.1 passage
• Extracellular Myocardial Volume in Patients With Aortic Stenosis.1 passage
• Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.1 passage
• Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction.1 passage
• Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.1 passage
• Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research.1 passage
• Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week.1 passage
• Factors Predisposing to Survival After Resuscitation for Sudden Cardiac Arrest.1 passage
• Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.1 passage
• Familial Hypercholesterolemia: JACC Focus Seminar 4/4.1 passage
• Family-Based Approaches to Cardiovascular Health Promotion.1 passage
• Fasting or Nonfasting Lipid Measurements: It Depends on the Question.1 passage
• Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.1 passage
• Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular Disease.1 passage
• Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.1 passage
• Favorable Impact on LDL Particle Size in Response to Treatment With Pioglitazone is Associated With Less Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes.1 passage
• Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.1 passage
• Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.1 passage
• Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.1 passage
• Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic.1 passage
• Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles.1 passage
• Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.1 passage
• Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.1 passage
• Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.1 passage
• Fibrous Cap Thickness by Optical Coherence Tomography In Vivo.1 passage
• Finding the Gatekeeper to the Cardiac Catheterization Laboratory: Coronary CT Angiography or Stress Testing?1 passage
• Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.1 passage
• First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.1 passage
• First-in-Human Closed-Chest Transcatheter Superior Cavopulmonary Anastomosis.1 passage
• First-in-Man Experience of a Novel Transcatheter Repair System for Treating Severe Tricuspid Regurgitation.1 passage
• First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve.1 passage
• Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.1 passage
• Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation: JACC Review Topic of the Week.1 passage
• Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.1 passage
• Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation.1 passage
• Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.1 passage
• Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.1 passage
• Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting.1 passage
• Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.1 passage
• Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.1 passage
• Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.1 passage
• Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.1 passage
• From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).1 passage
• From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review.1 passage
• From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week.1 passage
• From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review.1 passage
• Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us.1 passage
• Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.1 passage
• Fully Automated Versus Standard Tracking of Left Ventricular Ejection Fraction and Longitudinal Strain: The FAST-EFs Multicenter Study.1 passage
• Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.1 passage
• Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.1 passage
• Functional Aortic Root Parameters and Expression of Aortopathy in Bicuspid Versus Tricuspid Aortic Valve Stenosis.1 passage
• Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.1 passage
• Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease.1 passage
• Functional tricuspid regurgitation: a need to revise our understanding.1 passage
• Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.1 passage
• Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Future of Personalized Cardiovascular Medicine: JACC State-of-the-Art Review.1 passage
• Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease.1 passage
• Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.1 passage
• Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.1 passage
• Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.1 passage
• Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.1 passage
• Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States.1 passage
• Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.1 passage
• Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.1 passage
• Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.1 passage
• Generalizability of SPRINT Results to the U.S. Adult Population.1 passage
• Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.1 passage
• Genetic Basis of Severe Childhood-Onset Cardiomyopathies.1 passage
• Genetic Etiology for Alcohol-Induced Cardiac Toxicity.1 passage
• Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.1 passage
• Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.1 passage
• Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.1 passage
• Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk.1 passage
• Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.1 passage
• Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.1 passage
• Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.1 passage
• Genetics of Type 2 Diabetes: Opportunities for Precision Medicine: JACC Focus Seminar.1 passage
• Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.1 passage
• Genetics: Implications for Prevention and Management of Coronary Artery Disease.1 passage
• Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.1 passage
• Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.1 passage
• Genome-Wide Assessment for Resting Heart Rate and Shared Genetics With Cardiometabolic Traits and Type 2 Diabetes.1 passage
• Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders.1 passage
• Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.1 passage
• Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).1 passage
• Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates.1 passage
• Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain.1 passage
• Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.1 passage
• Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.1 passage
• Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.1 passage
• Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.1 passage
• Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.1 passage
• Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace.1 passage
• Global Prospective Safety Analysis of Rivaroxaban.1 passage
• Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.1 passage
• Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.1 passage
• Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes.1 passage
• Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting.1 passage
• Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya.1 passage
• Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain.1 passage
• HIV and Ischemic Heart Disease.1 passage
• HIV and Nonischemic Heart Disease.1 passage
• HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.1 passage
• HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic.1 passage
• Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.1 passage
• Has Prasugrel Been Compared Correctly With Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome?1 passage
• Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.1 passage
• Healed Culprit Plaques in Patients With Acute Coronary Syndromes.1 passage
• Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.1 passage
• Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.1 passage
• Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial.1 passage
• Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults.1 passage
• Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.1 passage
• Healthy Weight and Obesity Prevention: JACC Health Promotion Series.1 passage
• Healthy lifestyle in the primordial prevention of cardiovascular disease among young women.1 passage
• Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.1 passage
• Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.1 passage
• Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.1 passage
• Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.1 passage
• Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.1 passage
• Heart Failure-Induced Brain Injury.1 passage
• Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.1 passage
• Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.1 passage
• Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients.1 passage
• Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.1 passage
• Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.1 passage
• Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.1 passage
• Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction.1 passage
• Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation.1 passage
• Hemodynamics of Mechanical Circulatory Support.1 passage
• Hemoglobin Level and Hospital Mortality Among ICU Patients With Cardiac Disease Who Received Transfusions.1 passage
• Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review.1 passage
• Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies.1 passage
• Herbal Medications in Cardiovascular Medicine.1 passage
• High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction.1 passage
• High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.1 passage
• High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.1 passage
• High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.1 passage
• High-Output Heart Failure: A 15-Year Experience.1 passage
• High-Risk Cardiac Disease in Pregnancy: Part I.1 passage
• High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.1 passage
• High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.1 passage
• High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.1 passage
• High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.1 passage
• High-Sensitivity Troponins and Outcomes After Myocardial Infarction.1 passage
• His Bundle Pacing.1 passage
• His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.1 passage
• Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.1 passage
• Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.1 passage
• Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.1 passage
• Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.1 passage
• Home-Time After Discharge Among Patients Hospitalized With Heart Failure.1 passage
• Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes.1 passage
• Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry.1 passage
• Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry.1 passage
• Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.1 passage
• Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes.1 passage
• HotBalloon Ablation of the Pulmonary Veins for Paroxysmal AF: A Multicenter Randomized Trial in Japan.1 passage
• Household Disposable Income and Long-Term Survival After Cardiac Surgery: A Swedish Nationwide Cohort Study in 100,534 Patients.1 passage
• How Can a Cardiovascular Research Fellowship in the United States Affect the Career of a European Physician?1 passage
• How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.1 passage
• How Medicine Has Changed the End of Life for Patients With Cardiovascular Disease.1 passage
• How recent data have impacted the treatment of internal carotid artery stenosis.1 passage
• Human ventricular unloading induces cardiomyocyte proliferation.1 passage
• Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.1 passage
• Hybrid coronary revascularization: promising, but yet to take off.1 passage
• Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.1 passage
• Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.1 passage
• Hyperacute Management of Ischemic Strokes: JACC Focus Seminar.1 passage
• Hyperkalemia in Heart Failure.1 passage
• Hypertension Across a Woman's Life Cycle.1 passage
• Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.1 passage
• Hypertensive Disorders of Pregnancy and CVD Prediction: Accounting for Risk Accrual During the Reproductive Years.1 passage
• Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality.1 passage
• Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.1 passage
• Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.1 passage
• Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease.1 passage
• Hyponatremia in acute decompensated heart failure: depletion versus dilution.1 passage
• Ideal Blood Pressure in Patients With Atrial Fibrillation.1 passage
• Ideal Cardiovascular Health, Mortality, and Vascular Events in Elderly Subjects: The Three-City Study.1 passage
• Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.1 passage
• Identification of Typical Left Bundle Branch Block Contraction by Strain Echocardiography Is Additive to Electrocardiography in Prediction of Long-Term Outcome After Cardiac Resynchronization Therapy.1 passage
• Identification of Undetected Monogenic Cardiovascular Disorders.1 passage
• Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.1 passage
• Idiopathic Ventricular Arrhythmias Originating From the Pulmonary Sinus Cusp: Prevalence, Electrocardiographic/Electrophysiological Characteristics, and Catheter Ablation.1 passage
• Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review.1 passage
• Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.1 passage
• Imaging of Vulnerable Intracranial Atherosclerotic Plaque for Embolic Stroke of Undetermined Source.1 passage
• Imaging systemic inflammatory networks in ischemic heart disease.1 passage
• Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.1 passage
• Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.1 passage
• Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.1 passage
• Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.1 passage
• Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI.1 passage
• Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.1 passage
• Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.1 passage
• Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.1 passage
• Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse.1 passage
• Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.1 passage
• Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.1 passage
• Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis.1 passage
• Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.1 passage
• Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study.1 passage
• Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.1 passage
• Impact of Live, Scientific Annual Meetings in Today's Cardiovascular World.1 passage
• Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease.1 passage
• Impact of New Guidelines of Unscheduled and Scheduled Sedation for Cardiologists: JACC Council Perspectives.1 passage
• Impact of Obesity on Outcomes of Pregnancy in Women With Heart Disease.1 passage
• Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.1 passage
• Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.1 passage
• Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.1 passage
• Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease.1 passage
• Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.1 passage
• Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.1 passage
• Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention.1 passage
• Impact of Procedure Time on Outcomes of Thrombectomy for Stroke.1 passage
• Impact of Racial and Ethnic Disparities on Patients With Dilated Cardiomyopathy: JACC Focus Seminar 7/9.1 passage
• Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.1 passage
• Impact of Side Branch Modeling on Computation of Endothelial Shear Stress in Coronary Artery Disease: Coronary Tree Reconstruction by Fusion of 3D Angiography and OCT.1 passage
• Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.1 passage
• Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.1 passage
• Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease.1 passage
• Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.1 passage
• Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis.1 passage
• Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.1 passage
• Impact of statins on serial coronary calcification during atheroma progression and regression.1 passage
• Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.1 passage
• Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.1 passage
• Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week.1 passage
• Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.1 passage
• Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction.1 passage
• Implantable Cardiac Defibrillator Lead Failure and Management.1 passage
• Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.1 passage
• Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.1 passage
• Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.1 passage
• Implantable Electronic Cardiac Devices and Compatibility With Magnetic Resonance Imaging.1 passage
• Implantable Hemodynamic Monitoring for Heart Failure Patients.1 passage
• Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.1 passage
• Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events.1 passage
• Implementation of Transcatheter Aortic Valve Replacement in France.1 passage
• Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.1 passage
• Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).1 passage
• Implications of Elevated Pulmonary Artery Pressure for Transcatheter Mitral Repair: Time for Comprehensive Hemodynamic Investigation.1 passage
• Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART Registry.1 passage
• Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.1 passage
• Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents.1 passage
• Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH.1 passage
• Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients.1 passage
• Improved Outcomes of Heart Transplantation in Adults With Congenital Heart Disease Receiving Regionalized Care.1 passage
• Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.1 passage
• Improved Survival After the Ross Procedure Compared With Mechanical Aortic Valve Replacement.1 passage
• Improvement in Clinical Outcomes With Biventricular Versus Right Ventricular Pacing: The BLOCK HF Study.1 passage
• Improvement in Pediatric Cardiac Surgical Outcomes Through Interhospital Collaboration.1 passage
• Improving Atrial Fibrillation Therapy: Is There a Gene for That?1 passage
• Improving Communication in Heart Failure Patient Care.1 passage
• Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.1 passage
• Improving Longitudinal Outcomes, Efficiency, and Equity in the Care of Patients With Congenital Heart Disease.1 passage
• Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.1 passage
• Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week.1 passage
• Improving the Appropriate Use of Transthoracic Echocardiography: The Echo WISELY Trial.1 passage
• Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review.1 passage
• In Silico Trial of Optimized Versus Actual Public Defibrillator Locations.1 passage
• In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation Acute Coronary Syndrome.1 passage
• In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.1 passage
• Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy.1 passage
• Incidence and Outcomes of Pneumonia in Patients With Heart Failure.1 passage
• Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction.1 passage
• Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.1 passage
• Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.1 passage
• Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation.1 passage
• Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement.1 passage
• Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.1 passage
• Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting.1 passage
• Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After Transcatheter Aortic Valve Replacement: Multicenter Registry.1 passage
• Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.1 passage
• Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.1 passage
• Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease.1 passage
• Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.1 passage
• Increased PTPN22 expression and defective CREB activation impair regulatory T-cell differentiation in non-ST-segment elevation acute coronary syndromes.1 passage
• Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives.1 passage
• Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.1 passage
• Incretin-Based Therapy for Diabetes: What a Cardiologist Needs to Know.1 passage
• Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.1 passage
• Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.1 passage
• Infective Endocarditis After Transcatheter Aortic Valve Replacement.1 passage
• Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse.1 passage
• Infective Endocarditis in Patients on Chronic Hemodialysis.1 passage
• Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis.1 passage
• Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction.1 passage
• Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis.1 passage
• Inflammation in Heart Failure: JACC State-of-the-Art Review.1 passage
• Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.1 passage
• Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week.1 passage
• Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency.1 passage
• Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.1 passage
• Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.1 passage
• Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus.1 passage
• Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.1 passage
• Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review.1 passage
• Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias.1 passage
• Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The Xe-Hypotheca Trial.1 passage
• Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.1 passage
• Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial.1 passage
• Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.1 passage
• Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States.1 passage
• Initial Experience of Transcatheter Mitral Valve Replacement With a Novel Transcatheter Mitral Valve: Procedural and 6-Month Follow-Up Results.1 passage
• Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.1 passage
• Initial Findings From the North American COVID-19 Myocardial Infarction Registry.1 passage
• Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction.1 passage
• Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis.1 passage
• Injection Drug Use: A Minor Criterion With Major Implications for Patients With Infective Endocarditis.1 passage
• Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction.1 passage
• Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.1 passage
• Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.1 passage
• Integrated Clinical and Magnetic Resonance Imaging Assessments Late After Fontan Operation.1 passage
• Integrating Coronary Physiology, Longitudinal Pressure, and Perfusion Gradients in CAD: Measurements, Meaning, and Mortality.1 passage
• Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.1 passage
• Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis.1 passage
• Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.1 passage
• Interleukin-1β and Risk of Premature Death in Patients With Myocardial Infarction.1 passage
• International Fetal Cardiac Intervention Registry: A Worldwide Collaborative Description and Preliminary Outcomes.1 passage
• International Impact of COVID-19 on the Diagnosis of Heart Disease.1 passage
• International Mobile-Health Intervention on Physical Activity, Sitting, and Weight: The Stepathlon Cardiovascular Health Study.1 passage
• International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19.1 passage
• International Recommendations for Electrocardiographic Interpretation in Athletes.1 passage
• Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.1 passage
• Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.1 passage
• Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.1 passage
• Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction.1 passage
• Interventional Cardiology and Acute Stroke Care Going Forward: JACC Review Topic of the Week.1 passage
• Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Interventional Treatment of Patients With Congenital Heart Disease: Nationwide Danish Experience Over 39 Years.1 passage
• Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.1 passage
• Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.1 passage
• Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.1 passage
• Intracranial Arterial Calcification: Prevalence, Risk Factors, and Consequences: JACC Review Topic of the Week.1 passage
• Intracranial Atherosclerotic Plaque and Embolic Stroke of Undetermined Source: Another Piece of the Puzzle.1 passage
• Intracranial Atherosclerotic Plaque as a Potential Cause of Embolic Stroke of Undetermined Source.1 passage
• Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the Week.1 passage
• Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease.1 passage
• Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.1 passage
• Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future?1 passage
• Invasive Procedures Associated With the Development of Infective Endocarditis.1 passage
• Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.1 passage
• Is Atrial Fibrillation a Preventable Disease?1 passage
• Ischemia and Infarction in STEMI Patients With Multivessel Disease: Insights From the CvLPRIT Nuclear Substudy.1 passage
• Ischemic Event Rates in Very-High-Risk Adults.1 passage
• Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week.1 passage
• Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk.1 passage
• Isolated Noncompaction of the Left Ventricle in Adults.1 passage
• Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.1 passage
• Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study.1 passage
• Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.1 passage
• KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.1 passage
• KLF15-Wnt-Dependent Cardiac Reprogramming Up-Regulates SHISA3 in the Mammalian Heart.1 passage
• Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.1 passage
• Kawasaki Disease.1 passage
• Kidney Dysfunction and the Risk of Developing Aortic Stenosis.1 passage
• Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.1 passage
• Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.1 passage
• Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.1 passage
• Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women: The Women's Heart Alliance.1 passage
• LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.1 passage
• Lack of Association Between Heart Failure and Incident Cancer.1 passage
• Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease.1 passage
• Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke.1 passage
• Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review.1 passage
• Late Causes of Death After Pediatric Cardiac Surgery: A 60-Year Population-Based Study.1 passage
• Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.1 passage
• Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.1 passage
• Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.1 passage
• Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death.1 passage
• Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.1 passage
• Leadless Cardiac Pacemakers: Back to the Future.1 passage
• Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.1 passage
• Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach.1 passage
• Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.1 passage
• Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study.1 passage
• Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.1 passage
• Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.1 passage
• Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial.1 passage
• Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.1 passage
• Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.1 passage
• Left Bundle Branch Pacing: JACC Review Topic of the Week.1 passage
• Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.1 passage
• Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.1 passage
• Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.1 passage
• Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.1 passage
• Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.1 passage
• Left Ventricular Assist Devices for Lifelong Support.1 passage
• Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.1 passage
• Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis.1 passage
• Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?1 passage
• Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?1 passage
• Left Ventricular Scar and Prognosis in Chronic Chagas Cardiomyopathy.1 passage
• Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.1 passage
• Left Ventricular Unloading During Extracorporeal Membrane Oxygenation: Insights From Meta-Analyzed Observational Data Corrected for Confounders.1 passage
• Leptin in Leanness and Obesity: JACC State-of-the-Art Review.1 passage
• Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.1 passage
• Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".1 passage
• Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.1 passage
• Life Expectancy After Surgical Aortic Valve Replacement.1 passage
• Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race: A Cohort-Based Study of Medicare Beneficiaries.1 passage
• Lifespan Perspective on Congenital Heart Disease Research: JACC State-of-the-Art Review.1 passage
• Lifestyle Modifications for Preventing and Treating Heart Failure.1 passage
• Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.1 passage
• Lignan Intake and Risk of Coronary Heart Disease.1 passage
• Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.1 passage
• Limitations of Repeat Revascularization as an Outcome Measure: JACC Review Topic of the Week.1 passage
• Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and Kidneys.1 passage
• Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.1 passage
• Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar.1 passage
• Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.1 passage
• Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.1 passage
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.1 passage
• Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.1 passage
• Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.1 passage
• Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.1 passage
• Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis.1 passage
• Long Noncoding RNAs in Atherosclerosis: JACC Review Topic of the Week.1 passage
• Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?1 passage
• Long Working Hours and Risk of Recurrent Coronary Events.1 passage
• Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.1 passage
• Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.1 passage
• Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.1 passage
• Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.1 passage
• Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy.1 passage
• Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes: JACC Review Topic of the Week.1 passage
• Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.1 passage
• Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.1 passage
• Long-Term Durability of Transcatheter Aortic Valve Prostheses.1 passage
• Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).1 passage
• Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia.1 passage
• Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.1 passage
• Long-Term Evolution of Premature Coronary Artery Disease.1 passage
• Long-Term Exposure to Fine Particulate Matter and Cardiovascular Disease in China.1 passage
• Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.1 passage
• Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.1 passage
• Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.1 passage
• Long-Term Kidney Function After the Fontan Operation: JACC Review Topic of the Week.1 passage
• Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.1 passage
• Long-Term Mortality Following Transcatheter Atrial Septal Defects Closure in Comparison to the General Population.1 passage
• Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.1 passage
• Long-Term Outcomes After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting by Experienced Surgeons.1 passage
• Long-Term Outcomes Following Surgical Aortic Bioprosthesis Implantation.1 passage
• Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization.1 passage
• Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.1 passage
• Long-Term Outcomes in Patients With Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction.1 passage
• Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention.1 passage
• Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis.1 passage
• Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.1 passage
• Long-Term Outcomes of On- Versus Off-Pump Coronary Artery Bypass Grafting.1 passage
• Long-Term Outcomes of Patients Undergoing the Ross Procedure.1 passage
• Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.1 passage
• Long-Term Outcomes of Primary Cardiac Malignancies: Multi-Institutional Results From the National Cancer Database.1 passage
• Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?1 passage
• Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest.1 passage
• Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve.1 passage
• Long-Term Prognosis of Patients With Takotsubo Syndrome.1 passage
• Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.1 passage
• Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.1 passage
• Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy.1 passage
• Long-Term Results of Mitral Valve Repair for Regurgitation Due to Leaflet Prolapse.1 passage
• Long-Term Risk for Aortic Complications After Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Versus Marfan Syndrome.1 passage
• Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement.1 passage
• Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.1 passage
• Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.1 passage
• Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients.1 passage
• Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.1 passage
• Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.1 passage
• Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.1 passage
• Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification.1 passage
• Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care.1 passage
• Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting.1 passage
• Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.1 passage
• Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.1 passage
• Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.1 passage
• Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.1 passage
• Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.1 passage
• Loss in Life Expectancy After Surgical Aortic Valve Replacement: SWEDEHEART Study.1 passage
• Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.1 passage
• Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality.1 passage
• Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.1 passage
• Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention.1 passage
• Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.1 passage
• Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery.1 passage
• Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation.1 passage
• Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.1 passage
• Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.1 passage
• Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals.1 passage
• Machine Learning and the Future of Cardiovascular Care: JACC State-of-the-Art Review.1 passage
• Machine-Learning Algorithms to Automate Morphological and Functional Assessments in 2D Echocardiography.1 passage
• Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease: JACC Macrophage in CVD Series (Part 1).1 passage
• Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).1 passage
• Magnetic Resonance in Transthyretin Cardiac Amyloidosis.1 passage
• Magnetically-controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-induced Gastrointestinal Injury.1 passage
• Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization.1 passage
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.1 passage
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.1 passage
• Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials.1 passage
• Malaria and the Heart: JACC State-of-the-Art Review.1 passage
• Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.1 passage
• Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.1 passage
• Management of Acute Ischemic Stroke Due to Large-Vessel Occlusion: JACC Focus Seminar.1 passage
• Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).1 passage
• Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.1 passage
• Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.1 passage
• Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.1 passage
• Management of Intracerebral Hemorrhage: JACC Focus Seminar.1 passage
• Management of Obesity in Cardiovascular Practice: JACC Focus Seminar.1 passage
• Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.1 passage
• Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week.1 passage
• Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines.1 passage
• Management of Periprocedural Anticoagulation: A Survey of Contemporary Practice.1 passage
• Management of Pulmonary Embolism: An Update.1 passage
• Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.1 passage
• Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.1 passage
• Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.1 passage
• Management of pulmonary arterial hypertension.1 passage
• Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.1 passage
• Marfan Syndrome and Quality of Life in the GenTAC Registry.1 passage
• Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week.1 passage
• Marine n-3 Fatty Acids and the Risk of Peripheral Arterial Disease.1 passage
• Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.1 passage
• Maternal Comorbidities and Complications of Delivery in Pregnant Women With Congenital Heart Disease.1 passage
• Maternal Overweight and Obesity and Risk of Congenital Heart Defects.1 passage
• Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.1 passage
• Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis.1 passage
• Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.1 passage
• Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis.1 passage
• Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review.1 passage
• Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta-Analysis of Randomized Trials.1 passage
• Mechanical Unloading in Heart Failure.1 passage
• Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells.1 passage
• Mechanisms and clinical consequences of untreated central sleep apnea in heart failure.1 passage
• Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.1 passage
• Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.1 passage
• Mechanisms of Vascular Aging, A Geroscience Perspective: JACC Focus Seminar.1 passage
• Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.1 passage
• Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant.1 passage
• Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Medial Arterial Calcification: JACC State-of-the-Art Review.1 passage
• Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.1 passage
• Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.1 passage
• Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review.1 passage
• Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.1 passage
• Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.1 passage
• Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.1 passage
• Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?1 passage
• Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.1 passage
• Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.1 passage
• Metabolic Surgery: Weight Loss, Diabetes, and Beyond.1 passage
• Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.1 passage
• Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.1 passage
• Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.1 passage
• Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.1 passage
• Metoprolol in Critically Ill Patients With COVID-19.1 passage
• MicroRNAs in Cardiovascular Disease.1 passage
• Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation.1 passage
• Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring Replacement.1 passage
• Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up.1 passage
• Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell-Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium.1 passage
• Mitral Annulus Calcification.1 passage
• Mitral Regurgitation and Evolving Transcatheter Treatments: Insights From the JACC Family of Journals.1 passage
• Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures.1 passage
• Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.1 passage
• Mitral valve area during exercise after restrictive mitral valve annuloplasty: importance of diastolic anterior leaflet tethering.1 passage
• Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.1 passage
• Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.1 passage
• Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation.1 passage
• Mode of Death in Heart Failure With Preserved Ejection Fraction.1 passage
• Modeling Cardiovascular Risks of E-Cigarettes With Human-Induced Pluripotent Stem Cell-Derived Endothelial Cells.1 passage
• Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.1 passage
• Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.1 passage
• Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• Moderate Intensity Exercise Training Improves Skeletal Muscle Performance in Symptomatic and Asymptomatic Statin Users.1 passage
• Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.1 passage
• Modifiable Risk Factors in Young Adults With First Myocardial Infarction.1 passage
• Molecular Aspects of Lifestyle and Environmental Effects in Patients With Diabetes: JACC Focus Seminar.1 passage
• Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry.1 passage
• Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).1 passage
• Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.1 passage
• Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.1 passage
• Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.1 passage
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.1 passage
• Mortality From Bleeding Versus Myocardial Infarction: Loosening A Strand of the Antithrombotic Therapy "Gordian Knot".1 passage
• Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.1 passage
• Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.1 passage
• Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.1 passage
• Moving From Digitalization to Digitization in Cardiovascular Care: Why Is it Important, and What Could it Mean for Patients and Providers?1 passage
• Multi-Ethnic Study of Atherosclerosis (MESA): JACC Focus Seminar 5/8.1 passage
• Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement.1 passage
• Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel.1 passage
• Multimorbidity in Older Adults With Cardiovascular Disease.1 passage
• Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.1 passage
• Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.1 passage
• Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.1 passage
• Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.1 passage
• Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.1 passage
• Musculoskeletal Pain and Cancer Risk of Staff Working With Fluoroscopically Guided Procedures.1 passage
• Mutations in a TGF-β ligand, TGFB3, cause syndromic aortic aneurysms and dissections.1 passage
• Myocardial Angiotensin Metabolism in End-Stage Heart Failure.1 passage
• Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review.1 passage
• Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.1 passage
• Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.1 passage
• Myocardial Edema and Prognosis in Amyloidosis.1 passage
• Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.1 passage
• Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.1 passage
• Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.1 passage
• Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I.1 passage
• Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.1 passage
• Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.1 passage
• Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.1 passage
• Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1 passage
• Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective.1 passage
• Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.1 passage
• Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy: JACC Review Topic of the Week.1 passage
• Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.1 passage
• Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.1 passage
• N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.1 passage
• NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.1 passage
• NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.1 passage
• National Institutes of Health Career Development Awards for Cardiovascular Physician-Scientists: Recent Trends and Strategies for Success.1 passage
• National Trends and Outcomes in Isolated Tricuspid Valve Surgery.1 passage
• Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.1 passage
• Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease.1 passage
• Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.1 passage
• Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.1 passage
• Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.1 passage
• Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.1 passage
• Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance.1 passage
• Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders.1 passage
• Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.1 passage
• Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis.1 passage
• Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.1 passage
• Negative Risk Markers for Cardiovascular Events in the Elderly.1 passage
• Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.1 passage
• Neonatal Brain Injury and Timing of Neurodevelopmental Assessment in Patients With Congenital Heart Disease.1 passage
• Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation.1 passage
• Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.1 passage
• Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33°C and 36°C.1 passage
• Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study.1 passage
• Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.1 passage
• New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review.1 passage
• New Therapies for Lowering Triglyceride-Rich Lipoproteins: JACC Focus Seminar 3/4.1 passage
• New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.1 passage
• New perspectives on the prevalence of hypertrophic cardiomyopathy.1 passage
• New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.1 passage
• Newsflash, PCI Works: Stenting Stenoses Increases Coronary Blood Flow During Exercise and Reduces Ischemia.1 passage
• Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.1 passage
• Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.1 passage
• Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.1 passage
• Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.1 passage
• Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week.1 passage
• Nonsyndromic Thoracic Aortic Aneurysm and Dissection: Outcomes With Marfan Syndrome Versus Bicuspid Aortic Valve Aneurysm.1 passage
• Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.1 passage
• Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.1 passage
• Normalization of Visceral Fat and Complete Reversal of Cardiovascular Remodeling Accompany Gastric Bypass, not Banding.1 passage
• Notes From the Eye of the Storm: Trainees at the Frontlines of the COVID-19 Pandemic.1 passage
• Novel Diabetes Drugs and the Cardiovascular Specialist.1 passage
• Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification.1 passage
• Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging.1 passage
• Nut Consumption and Risk of Cardiovascular Disease.1 passage
• Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.1 passage
• Obesity as a Causal Risk Factor for Aortic Valve Stenosis.1 passage
• Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.1 passage
• Obesity: Pathophysiology and Management.1 passage
• Occupational health hazards of working in the interventional laboratory: a multisite case control study of physicians and allied staff.1 passage
• Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.1 passage
• Off-Pump Versus On-Pump Bypass Surgery for Left Main Coronary Artery Disease.1 passage
• Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.1 passage
• On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.1 passage
• Ongoing Methodological Approaches to Improve the In Vivo Assessment of Local Coronary Blood Flow and Endothelial Shear Stress: The Devil Is in the Details.1 passage
• Open Atrial Transcatheter Mitral Valve Replacement in Patients With Mitral Annular Calcification.1 passage
• Operational Efficiency and Effective Management in the Catheterization Laboratory: JACC Review Topic of the Week.1 passage
• Operationalizing the 2014 ACC/AHA Guidelines for Valvular Heart Disease: A Guide for Clinicians.1 passage
• Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States.1 passage
• Optical Coherence Tomography of Coronary Plaque Progression and Destabilization: JACC Focus Seminar Part 3/3.1 passage
• Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3.1 passage
• Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Part 1/3.1 passage
• Optimal Treatment of Uncomplicated Type B Aortic Dissection: JACC Review Topic of the Week.1 passage
• Optimizing Cholesterol Treatment in Patients With Muscle Complaints.1 passage
• Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin.1 passage
• Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest.1 passage
• Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.1 passage
• Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.1 passage
• Oral Anticoagulation in Patients With Liver Disease.1 passage
• Oral Fluoroquinolone and the Risk of Aortic Dissection.1 passage
• Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation.1 passage
• Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.1 passage
• Orthopedic afflictions in the interventional laboratory: tales from the working wounded.1 passage
• Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment.1 passage
• Orthostatic Hypotension: JACC State-of-the-Art Review.1 passage
• Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.1 passage
• Out-of-Hospital Cardiac Arrest and Acute Coronary Syndrome Hospitalizations During the COVID-19 Surge.1 passage
• Outcome and Impact of Aortic Valve Replacement in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis.1 passage
• Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction.1 passage
• Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.1 passage
• Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.1 passage
• Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.1 passage
• Outcomes After Transplantation of Donor Hearts With Improving Left Ventricular Systolic Dysfunction.1 passage
• Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.1 passage
• Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.1 passage
• Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.1 passage
• Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report.1 passage
• Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines.1 passage
• Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?1 passage
• Outcomes in Patients With Chest Pain Discharged After Evaluation Using a High-Sensitivity Troponin T Assay.1 passage
• Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.1 passage
• Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.1 passage
• Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.1 passage
• Outcomes of Aortic Valve-Sparing Operations in Marfan Syndrome.1 passage
• Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.1 passage
• Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.1 passage
• Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.1 passage
• Outcomes of Donation After Circulatory Death Heart Transplantation in Australia.1 passage
• Outcomes of Endovascular Repair of Ascending Aortic Dissection in Patients Unsuitable for Direct Surgical Repair.1 passage
• Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.1 passage
• Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.1 passage
• Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.1 passage
• Outcomes of Percutaneous Coronary Intervention Performed at Offsite Versus Onsite Surgical Centers in the United Kingdom.1 passage
• Outcomes of Pregnancy After Right Ventricular Outflow Tract Reconstruction With an Allograft Conduit.1 passage
• Outcomes of Second Arterial Conduits in Patients Undergoing Multivessel Coronary Artery Bypass Graft Surgery.1 passage
• Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes.1 passage
• Overcoming Spatial and Temporal Barriers to Public Access Defibrillators Via Optimization.1 passage
• Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United States.1 passage
• Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.1 passage
• Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.1 passage
• Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.1 passage
• Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.1 passage
• PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.1 passage
• PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease.1 passage
• PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week.1 passage
• PCSK9 Inhibitors: Economics and Policy.1 passage
• PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.1 passage
• PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.1 passage
• PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers.1 passage
• Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.1 passage
• Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.1 passage
• Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.1 passage
• Papillary Muscle Approximation Versus Restrictive Annuloplasty Alone for Severe Ischemic Mitral Regurgitation.1 passage
• Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.1 passage
• Patent foramen ovale and paradoxical systemic embolism: can we determine high-risk characteristics by echocardiography?1 passage
• Pathogenic FBN1 Genetic Variation and Aortic Dissection in Patients With Marfan Syndrome.1 passage
• Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week.1 passage
• Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.1 passage
• Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.1 passage
• Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review.1 passage
• Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.1 passage
• Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction.1 passage
• Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI.1 passage
• Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.1 passage
• Patient selection in heart failure with preserved ejection fraction clinical trials.1 passage
• Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.1 passage
• Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.1 passage
• Pediatric Appropriate Use Criteria Implementation Project: A Multicenter Outpatient Echocardiography Quality Initiative.1 passage
• Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy: The Importance of Hemodynamics.1 passage
• Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.1 passage
• Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.1 passage
• Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.1 passage
• Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.1 passage
• Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.1 passage
• Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: We Should EXPLORE More!1 passage
• Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.1 passage
• Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.1 passage
• Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.1 passage
• Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.1 passage
• Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.1 passage
• Percutaneous Pulmonary Valve Implantation: Present Status and Evolving Future.1 passage
• Percutaneous Transcatheter Mitral Valve Replacement: First-in-Human Experience With a New Transseptal System.1 passage
• Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.1 passage
• Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency Department.1 passage
• Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults.1 passage
• Performance on the Cardiovascular In-Training Examination in Relation to the ABIM Cardiovascular Disease Certification Examination.1 passage
• Pericardial Fat and the Risk of Heart Failure.1 passage
• Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery.1 passage
• Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry.1 passage
• Peripartum Cardiomyopathy: JACC State-of-the-Art Review.1 passage
• Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.1 passage
• Permanent Pacemaker Implantation After TAVR for Degenerated Bioprosthetic Surgical Valves: We Could Do Better.1 passage
• Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry.1 passage
• Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial.1 passage
• Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.1 passage
• Persistent Survival Benefit From Remote Ischemic Pre-Conditioning in Patients Undergoing Coronary Artery Bypass Surgery.1 passage
• Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial.1 passage
• Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.1 passage
• Phenotype and Clinical Outcomes of Titin Cardiomyopathy.1 passage
• Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.1 passage
• Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.1 passage
• Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents.1 passage
• Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction.1 passage
• Physical Activity and Mortality in Patients With Stable Coronary Heart Disease.1 passage
• Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction.1 passage
• Physiological Stress Elicits Impaired Left Ventricular Function in Preterm-Born Adults.1 passage
• Pim1 Kinase Overexpression Enhances ckit1 passage
• Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.1 passage
• Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up.1 passage
• Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.1 passage
• Plasma exosomes protect the myocardium from ischemia-reperfusion injury.1 passage
• Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke.1 passage
• Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.1 passage
• Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.1 passage
• Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.1 passage
• Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine.1 passage
• Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis.1 passage
• Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.1 passage
• Poor Long-Term Survival in Patients With Moderate Aortic Stenosis.1 passage
• Population-Based Risk Factors for Ascending, Arch, Descending, and Abdominal Aortic Dilations for 60-74-Year-Old Individuals.1 passage
• Positive Cardiovascular Health: A Timely Convergence.1 passage
• Positive Pressure Ventilation in the Cardiac Intensive Care Unit.1 passage
• Positive Psychological Well-Being and Cardiovascular Disease: JACC Health Promotion Series.1 passage
• Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.1 passage
• Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.1 passage
• Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.1 passage
• Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR.1 passage
• Post-Operative Chylothorax in Patients With Congenital Heart Disease.1 passage
• Post-Operative Outcomes in Children With and Without Congenital Heart Disease Undergoing Noncardiac Surgery.1 passage
• Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.1 passage
• Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review.1 passage
• Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar.1 passage
• Potent P2Y1 passage
• Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China.1 passage
• Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.1 passage
• Practical management of anticoagulation in patients with atrial fibrillation.1 passage
• Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.1 passage
• Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.1 passage
• Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.1 passage
• Pre-Hospital Administration of Epinephrine in Pediatric Patients With Out-of-Hospital Cardiac Arrest.1 passage
• Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States.1 passage
• Pre-Term Delivery and Risk of Ischemic Heart Disease in Women.1 passage
• Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study.1 passage
• Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review.1 passage
• Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.1 passage
• Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5.1 passage
• Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5.1 passage
• Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.1 passage
• Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment.1 passage
• Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.1 passage
• Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.1 passage
• Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.1 passage
• Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.1 passage
• Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction.1 passage
• Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.1 passage
• Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.1 passage
• Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study.1 passage
• Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score.1 passage
• Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.1 passage
• Prediction of Abnormal Myocardial Relaxation From Signal Processed Surface ECG.1 passage
• Prediction of Future Overt Pulmonary Hypertension by 6-Min Walk Stress Echocardiography in Patients With Connective Tissue Disease.1 passage
• Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.1 passage
• Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.1 passage
• Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia.1 passage
• Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.1 passage
• Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database.1 passage
• Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.1 passage
• Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.1 passage
• Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.1 passage
• Predictors of Progression in Patients With Stage B Aortic Regurgitation.1 passage
• Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.1 passage
• Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review.1 passage
• Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study.1 passage
• Pregnancy-Related Aortic Complications in Women With Marfan Syndrome.1 passage
• Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week.1 passage
• Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week.1 passage
• Present Status of Brugada Syndrome: JACC State-of-the-Art Review.1 passage
• Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.1 passage
• Presentation, Diagnosis, and Outcomes of Acute Aortic Dissection: 17-Year Trends From the International Registry of Acute Aortic Dissection.1 passage
• Presenting Systolic Blood Pressure and Outcomes in Patients With Acute Aortic Dissection.1 passage
• Preterm Birth and Risk of Heart Failure Up to Early Adulthood.1 passage
• Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.1 passage
• Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.1 passage
• Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.1 passage
• Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.1 passage
• Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary Syndrome.1 passage
• Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia.1 passage
• Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.1 passage
• Prevalence of Pulmonary Embolism in Patients With Syncope.1 passage
• Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study.1 passage
• Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.1 passage
• Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week.1 passage
• Preventing Complications in Pregnant Women With Cardiac Disease.1 passage
• Prevention and Control of Hypertension: JACC Health Promotion Series.1 passage
• Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.1 passage
• Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.1 passage
• Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.1 passage
• Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel.1 passage
• Primary Aldosteronism in Patients in China With Recently Detected Hypertension.1 passage
• Primary Aldosteronism: JACC State-of-the-Art Review.1 passage
• Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement.1 passage
• Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.1 passage
• Primary Prevention With Statins in the Elderly.1 passage
• Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.1 passage
• Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art Review.1 passage
• Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.1 passage
• Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF.1 passage
• Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry.1 passage
• Procedural Success and Adverse Events in Pulmonary Artery Stenting: Insights From the NCDR.1 passage
• Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.1 passage
• Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death.1 passage
• Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.1 passage
• Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.1 passage
• Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes.1 passage
• Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation.1 passage
• Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.1 passage
• Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction.1 passage
• Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease.1 passage
• Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.1 passage
• Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.1 passage
• Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) Classification.1 passage
• Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.1 passage
• Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure.1 passage
• Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure.1 passage
• Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.1 passage
• Prognostic Value of1 passage
• Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis.1 passage
• Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.1 passage
• Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease.1 passage
• Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation.1 passage
• Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.1 passage
• Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.1 passage
• Prognostic Value of Plasma Soluble Corin in Patients With Acute Myocardial Infarction.1 passage
• Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis.1 passage
• Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.1 passage
• Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.1 passage
• Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas.1 passage
• Program Directors Survey on Diversity in Cardiovascular Training Programs.1 passage
• Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.1 passage
• Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8.1 passage
• Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.1 passage
• Progressive Aortic Dilation Is Regulated by miR-17-Associated miRNAs.1 passage
• Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.1 passage
• Promoting Physical Activity and Exercise: JACC Health Promotion Series.1 passage
• Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.1 passage
• Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.1 passage
• Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.1 passage
• Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction.1 passage
• Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry.1 passage
• Prosthetic Heart Valve Thrombosis.1 passage
• Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.1 passage
• Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.1 passage
• Protein-Losing Enteropathy in Patients With Congenital Heart Disease.1 passage
• Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.1 passage
• Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.1 passage
• Proteomics-Enabled Deep Learning Machine Algorithms Can Enhance Prediction of Mortality.1 passage
• Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.1 passage
• Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.1 passage
• Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry.1 passage
• Psychological Distress Across the Life Course and Cardiometabolic Risk: Findings From the 1958 British Birth Cohort Study.1 passage
• Psychopharmacology and Cardiovascular Disease.1 passage
• Publication Rates of Heart Failure Clinical Trials Remain Low.1 passage
• Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.1 passage
• Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy.1 passage
• Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.1 passage
• Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.1 passage
• Pulmonary Hypertension in Infants, Children, and Young Adults.1 passage
• Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.1 passage
• Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation.1 passage
• Pulmonary Vein Isolation Versus Defragmentation: The CHASE-AF Clinical Trial.1 passage
• Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.1 passage
• Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry.1 passage
• Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation.1 passage
• Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation.1 passage
• QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?1 passage
• Quality Assurance for Carotid Stenting in the CREST-2 Registry.1 passage
• Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.1 passage
• Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.1 passage
• Quality of Life of Adults With Congenital Heart Disease in 15 Countries: Evaluating Country-Specific Characteristics.1 passage
• Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.1 passage
• Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM.1 passage
• Race and Ethnicity Considerations in Patients With Coronary Artery Disease and Stroke: JACC Focus Seminar 3/9.1 passage
• Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.1 passage
• Race, Ethnicity, Hypertension, and Heart Disease: JACC Focus Seminar 1/9.1 passage
• Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.1 passage
• Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results.1 passage
• Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial.1 passage
• Radiation Exposure of Operators Performing Transesophageal Echocardiography During Percutaneous Structural Cardiac Interventions.1 passage
• Raising the Evidentiary Bar for Guideline Recommendations for TAVR: JACC Review Topic of the Week.1 passage
• Ramipril in High-Risk Patients With COVID-19.1 passage
• Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.1 passage
• Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.1 passage
• Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.1 passage
• Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.1 passage
• Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer.1 passage
• Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.1 passage
• Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week.1 passage
• Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week.1 passage
• Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.1 passage
• Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation.1 passage
• Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.1 passage
• Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.1 passage
• Rapid Deployment Versus Conventional Bioprosthetic Valve Replacement for Aortic Stenosis.1 passage
• Rare Genetic Variants Associated With Sudden Cardiac Death in Adults.1 passage
• Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.1 passage
• Readmissions after carotid artery revascularization in the Medicare population.1 passage
• Real Clinical Significance of Statin Cessation After Adjustment for Smoking Persistence and Antiplatelet Treatment Discontinuation.1 passage
• Recent Endovascular Stroke Trials and Their Impact on Stroke Systems of Care.1 passage
• Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.1 passage
• Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.1 passage
• Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction.1 passage
• Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.1 passage
• Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.1 passage
• Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure.1 passage
• Reduced Left Ventricular Ejection Fraction in Patients With Aortic Stenosis.1 passage
• Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.1 passage
• Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank Meeting.1 passage
• Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.1 passage
• Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.1 passage
• Reduction of Ischemic Time for Transferred STEMI Patients Using a Smartphone Social Network System.1 passage
• Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions.1 passage
• Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.1 passage
• Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.1 passage
• Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.1 passage
• Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future Trials.1 passage
• Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.1 passage
• Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.1 passage
• Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.1 passage
• Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults.1 passage
• Relationship of Iron Deposition to Calcium Deposition in Human Aortic Valve Leaflets.1 passage
• Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.1 passage
• Relationship of Ventricular Morphology and Atrioventricular Valve Function to Long-Term Outcomes Following Fontan Procedures.1 passage
• Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.1 passage
• Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.1 passage
• Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.1 passage
• Relevance of Fitness to Mortality Risk in Men Receiving Contemporary Medical Care.1 passage
• Reliability of Office, Home, and Ambulatory Blood Pressure Measurements and Correlation With Left Ventricular Mass.1 passage
• Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.1 passage
• Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes.1 passage
• Remote ischemic conditioning.1 passage
• Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.1 passage
• Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review.1 passage
• Renal Denervation in High-Risk Patients With Hypertension.1 passage
• Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.1 passage
• Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.1 passage
• Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction.1 passage
• Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.1 passage
• Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.1 passage
• Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?1 passage
• Reply: Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?1 passage
• Reply: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.1 passage
• Reply: Electrocardiographic Criteria for Diagnosing Left Ventricular Hypertrophy and Predicting Mortality in Patients With Aortic Stenosis.1 passage
• Reply: Has Prasugrel Been Compared Correctly With Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome?1 passage
• Reply: Imaging of Vulnerable Intracranial Atherosclerotic Plaque for Embolic Stroke of Undetermined Source.1 passage
• Reply: Is it Time for a New Paradigm in Asymptomatic Severe Aortic Stenosis?: Asymptomatic Severe Aortic Stenosis: Oxymoron? A Randomized Trial in Patients With Asymptomatic Severe Aortic Stenosis: A Future Has Begun! Might Outcome of Patients With Asymptomatic Severe AS Be Improved by an Initial Surgical Strategy?1 passage
• Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.1 passage
• Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.1 passage
• Reply: Musculoskeletal Pain and Cancer Risk of Staff Working With Fluoroscopically Guided Procedures.1 passage
• Reply: Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.1 passage
• Reply: Statin Intolerance and Risk for Recurrent Myocardial Infarction, Coronary Heart Disease Events, and All-Cause Mortality.1 passage
• Reply: The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension: To "Cath" or Not in Pediatric Pulmonary Hypertension?1 passage
• Reply: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease: Aligning Treatment Goals With Expectations.1 passage
• Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease.1 passage
• Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention.1 passage
• Reply: patent foramen ovale and paradoxical systemic embolism: can we determine high-risk characteristics by echocardiography?1 passage
• Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies.1 passage
• Reprint of: Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.1 passage
• Reprint of: Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series.1 passage
• Reprint of: Healthy Weight and Obesity Prevention: JACC Health Promotion Series.1 passage
• Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.1 passage
• Reprint of: Positive Psychological Well-Being and Cardiovascular Disease: JACC Health Promotion Series.1 passage
• Reprint of: Prevention and Control of Hypertension: JACC Health Promotion Series.1 passage
• Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.1 passage
• Reprint of: Promoting Physical Activity and Exercise: JACC Health Promotion Series.1 passage
• Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative.1 passage
• Research Education and Mentoring Program in Cardiovascular Diseases for Under-Represented Junior Faculty From NHLBI SIPID/PRIDE.1 passage
• Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.1 passage
• Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults.1 passage
• Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.1 passage
• Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the Week.1 passage
• Retrograde Recanalization of Chronic Total Occlusions in Europe: Procedural, In-Hospital, and Long-Term Outcomes From the Multicenter ERCTO Registry.1 passage
• Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death.1 passage
• Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.1 passage
• Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.1 passage
• Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable?1 passage
• Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction.1 passage
• Revascularization in severe left ventricular dysfunction.1 passage
• Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.1 passage
• Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction.1 passage
• Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.1 passage
• Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel.1 passage
• Right Atrial/Pulmonary Arterial Wedge Pressure Ratio in Primary and Mixed Constrictive Pericarditis.1 passage
• Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.1 passage
• Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.1 passage
• Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation.1 passage
• Risk Associated With Valvular Regurgitation During Pregnancy.1 passage
• Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week.1 passage
• Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.1 passage
• Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis.1 passage
• Risk Stratification Among Survivors of Cardiac Arrest Considered for Coronary Angiography.1 passage
• Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.1 passage
• Risk of Aortic Dissection in the Moderately Dilated Ascending Aorta.1 passage
• Risk of Arterial Thromboembolism in Patients With Cancer.1 passage
• Risk of Cardiovascular Hospital Admission After Exposure to Fine Particulate Pollution.1 passage
• Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.1 passage
• Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.1 passage
• Risk of Pregnancy in Moderate and Severe Aortic Stenosis: From the Multinational ROPAC Registry.1 passage
• Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.1 passage
• Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.1 passage
• Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.1 passage
• Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.1 passage
• Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial.1 passage
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial.1 passage
• Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.1 passage
• Role of Cardiac Lymphatics in Myocardial Edema and Fibrosis: JACC Review Topic of the Week.1 passage
• Role of NOD1 in Heart Failure Progression via Regulation of Ca1 passage
• Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and Reimbursement.1 passage
• Role of Stress Kinase JNK in Binge Alcohol-Evoked Atrial Arrhythmia.1 passage
• Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.1 passage
• Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.1 passage
• Ross Procedure in Adults for Cardiologists and Cardiac Surgeons: JACC State-of-the-Art Review.1 passage
• Ross Procedures in Children With Previous Aortic Valve Surgery.1 passage
• SCAI Multi-Society Position Statement on Occupational Health Hazards of the Catheterization Laboratory: Shifting the Paradigm for Healthcare Workers' Protection.1 passage
• SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.1 passage
• ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.1 passage
• STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.1 passage
• SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.1 passage
• SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.1 passage
• Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership.1 passage
• Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.1 passage
• Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery Disease.1 passage
• Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.1 passage
• Safety and Efficacy of the Subcutaneous Implantable Defibrillator.1 passage
• Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.1 passage
• Safety of Transesophageal Echocardiography to Guide Structural Cardiac Interventions.1 passage
• Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials.1 passage
• Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study.1 passage
• Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.1 passage
• Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia.1 passage
• Scarce-Resource Allocation and Patient Triage During the COVID-19 Pandemic: JACC Review Topic of the Week.1 passage
• Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.1 passage
• Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations.1 passage
• Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling.1 passage
• Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week.1 passage
• Selecting Patients With Nonischemic Dilated Cardiomyopathy for ICDs: Myocardial Function, Fibrosis, and What's Attached?1 passage
• Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Stenosis.1 passage
• Semilunar Valve Interventions for Congenital Heart Disease: JACC State-of-the-Art Review.1 passage
• Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement.1 passage
• Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.1 passage
• Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.1 passage
• Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study.1 passage
• Sex Differences in Circulating Biomarkers of Cardiovascular Disease.1 passage
• Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease.1 passage
• Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.1 passage
• Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality.1 passage
• Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement.1 passage
• Sex Versus Gender-Related Characteristics: Which Predicts Outcome After Acute Coronary Syndrome in the Young?1 passage
• Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014.1 passage
• Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.1 passage
• Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction.1 passage
• Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries.1 passage
• Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.1 passage
• Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease.1 passage
• Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome.1 passage
• Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension.1 passage
• Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.1 passage
• Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study.1 passage
• Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.1 passage
• Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.1 passage
• Short-Term Exposure to Ambient Air Pollution and Mortality From Myocardial Infarction.1 passage
• Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.1 passage
• Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.1 passage
• Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.1 passage
• Should CMR Become the New Darling of Noninvasive Imaging for the Monitoring of Progression and Regression of Coronary Heart Disease?1 passage
• Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry.1 passage
• Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?1 passage
• Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?1 passage
• Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment.1 passage
• Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.1 passage
• Similarity and Difference of Resting Distal to Aortic Coronary Pressure and Instantaneous Wave-Free Ratio.1 passage
• Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia.1 passage
• Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain.1 passage
• Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.1 passage
• Sitting Time, Physical Activity, and Risk of Mortality in Adults.1 passage
• Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.1 passage
• Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Sleep Duration and Myocardial Infarction.1 passage
• Sleep Irregularity and Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.1 passage
• Smartphone Activation of Citizen Responders to Facilitate Defibrillation in Out-of-Hospital Cardiac Arrest.1 passage
• Smartwatch Algorithm for Automated Detection of Atrial Fibrillation.1 passage
• Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.1 passage
• Socioeconomic Determinants of Health and Cardiovascular Outcomes in Women: JACC Review Topic of the Week.1 passage
• Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection: JACC Review Topic of the Week.1 passage
• Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.1 passage
• Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.1 passage
• Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.1 passage
• Sonothrombolysis in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.1 passage
• Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.1 passage
• Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series.1 passage
• Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.1 passage
• Spontaneous Coronary Artery Dissection Associated With Pregnancy.1 passage
• Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.1 passage
• Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review.1 passage
• Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.1 passage
• Sports Cardiology: Core Curriculum for Providing Cardiovascular Care to Competitive Athletes and Highly Active People.1 passage
• Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy.1 passage
• Stable High-Sensitivity Cardiac Troponin T Levels and Outcomes in Patients With Chest Pain.1 passage
• Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis.1 passage
• Staging Cardiac Damage in Patients With Symptomatic Aortic Valve Stenosis.1 passage
• Standardization of Fractional Flow Reserve Measurements.1 passage
• Standardized Team-Based Care for Cardiogenic Shock.1 passage
• Staphylococcus Aureus Infective Endocarditis: JACC Patient Pathways.1 passage
• Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.1 passage
• Statin Intolerance and the Obsession With Aggressive Cholesterol Lowering to Prevent Coronary Heart Disease.1 passage
• Statin-Associated Side Effects.1 passage
• Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.1 passage
• Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.1 passage
• Statistical Appraisal of 6 Recent Clinical Trials in Cardiology: JACC State-of-the-Art Review.1 passage
• Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.1 passage
• Statistical Inference in Abstracts Published in Cardiovascular Journals.1 passage
• Status of Early-Career Academic Cardiology: A Global Perspective.1 passage
• Status of cardiovascular health in Chinese adults.1 passage
• Stem Cell-Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy.1 passage
• Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.1 passage
• Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.1 passage
• Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.1 passage
• Strain Echocardiography and Functional Capacity in Asymptomatic Primary Mitral Regurgitation With Preserved Ejection Fraction.1 passage
• Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.1 passage
• Strategies to incorporate left atrial appendage occlusion into clinical practice.1 passage
• Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial.1 passage
• Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week.1 passage
• Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.1 passage
• Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD.1 passage
• Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.1 passage
• Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease.1 passage
• Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.1 passage
• Stroke Associated With Infective Endocarditis After Transcatheter Aortic Valve Replacement Is Devastating.1 passage
• Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement.1 passage
• Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.1 passage
• Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.1 passage
• Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.1 passage
• Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.1 passage
• Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.1 passage
• Structural Valve Deterioration in Surgical Versus Transcatheter Aortic Valve Replacement: Comparing Apples to Oranges?1 passage
• Structure and Function of the Left Atrium and Left Atrial Appendage: AF and Stroke Implications.1 passage
• Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study.1 passage
• Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study.1 passage
• Subclinical Cardiovascular Disease and Death, Dementia, and Coronary Heart Disease in Patients 80+ Years.1 passage
• Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.1 passage
• Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.1 passage
• Sudden cardiac death in the older athlete.1 passage
• Sudden death in childhood cardiomyopathy: results from a long-term national population-based study.1 passage
• Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.1 passage
• Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.1 passage
• Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.1 passage
• Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.1 passage
• Supplemental Vitamins and Minerals for CVD Prevention and Treatment.1 passage
• Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.1 passage
• Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.1 passage
• Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.1 passage
• Surveillance Imaging Following Acute Type A Aortic Dissection.1 passage
• Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.1 passage
• Survival After Coronary Revascularization With Paclitaxel-Coated Balloons.1 passage
• Survival After Heart Transplantation in Patients Bridged With Mechanical Circulatory Support.1 passage
• Survival After Implantable Cardioverter-Defibrillator Shocks.1 passage
• Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.1 passage
• Survival and Right Ventricular Function After Surgical Management of Acute Pulmonary Embolism.1 passage
• Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.1 passage
• Sustainability of and Adherence to Preschool Health Promotion Among Children 9 to 13 Years Old.1 passage
• Sustained Physical Activity, Not Weight Loss, Associated With Improved Survival in Coronary Heart Disease.1 passage
• Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.1 passage
• Systematic Coronary Risk Evaluation (SCORE): JACC Focus Seminar 4/8.1 passage
• Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.1 passage
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.1 passage
• Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.1 passage
• Systematic Search for Present and Potential Portals of Entry for Infective Endocarditis.1 passage
• Systemic Sirolimus Therapy for Infants and Children With Pulmonary Vein Stenosis.1 passage
• Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement.1 passage
• Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure.1 passage
• Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension.1 passage
• Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.1 passage
• Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.1 passage
• TAVR for Stenotic Bicuspid Aortic Valve: Feasible, Continuously Improving Results With Another Red Flag.1 passage
• TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.1 passage
• Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology.1 passage
• Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.1 passage
• Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.1 passage
• Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.1 passage
• Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.1 passage
• Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review.1 passage
• Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.1 passage
• Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5.1 passage
• Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy.1 passage
• Telomere Length as Cardiovascular Aging Biomarker: JACC Review Topic of the Week.1 passage
• Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.1 passage
• Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry.1 passage
• Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States.1 passage
• Temporal Trends in Mechanical Complications of Acute Myocardial Infarction in the Elderly.1 passage
• Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.1 passage
• Temporal Trends of De Novo Malignancy Development After Heart Transplantation.1 passage
• Temporal changes in appropriateness of cardiac imaging.1 passage
• Temporary Circulatory Support in U.S. Children Awaiting Heart Transplantation.1 passage
• Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.1 passage
• Testosterone and Cardiovascular Disease.1 passage
• The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8.1 passage
• The Academic Medical System: Reinvention to Survive the Revolution in Health Care.1 passage
• The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.1 passage
• The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.1 passage
• The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar.1 passage
• The American College of Cardiology Roundtable on Research in the Era of COVID-19.1 passage
• The Benefit of Donor-Recipient Matching for Patients Undergoing Heart Transplantation.1 passage
• The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.1 passage
• The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.1 passage
• The Cardiovascular Effects of Cocaine.1 passage
• The Cardiovascular Risk of White-Coat Hypertension.1 passage
• The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.1 passage
• The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.1 passage
• The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.1 passage
• The Characteristics and Outcomes of Native Aortic Valve Thrombosis: A Systematic Review.1 passage
• The Choice of Conduits in Coronary Artery Bypass Surgery.1 passage
• The Clinical Use of Ivabradine.1 passage
• The Contextualized Genetics of Human Longevity: JACC Focus Seminar.1 passage
• The Continued Search for Physiological Pacing: Where Are We Now?1 passage
• The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis.1 passage
• The Coronary Artery Risk Development In Young Adults (CARDIA) Study: JACC Focus Seminar 8/8.1 passage
• The Diagnosis and Evaluation of Dilated Cardiomyopathy.1 passage
• The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy.1 passage
• The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited?1 passage
• The Early Repolarization Pattern: A Consensus Paper.1 passage
• The Effect of Blood Lipids on the Left Ventricle: A Mendelian Randomization Study.1 passage
• The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.1 passage
• The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.1 passage
• The Essential Role of Educator Development: 10 Years of the ACC Emerging Faculty Program.1 passage
• The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).1 passage
• The Evolving Future of Instantaneous Wave-Free Ratio and Fractional Flow Reserve.1 passage
• The Evolving Future of PCSK9 Inhibitors.1 passage
• The Evolving Nature of Infective Endocarditis in Spain: A Population-Based Study (2003 to 2014).1 passage
• The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease.1 passage
• The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry.1 passage
• The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week.1 passage
• The Impact of COVID-19 on Cardiovascular Training Programs: Challenges, Responsibilities, and Opportunities.1 passage
• The Impact of Pre-Operative Malperfusion on Outcome in Acute Type A Aortic Dissection: Results From the GERAADA Registry.1 passage
• The Importance of Breakfast in Atherosclerosis Disease: Insights From the PESA Study.1 passage
• The Importance of Global Health Experiences in the Development of New Cardiologists.1 passage
• The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.1 passage
• The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.1 passage
• The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).1 passage
• The Mitral Annulus Disjunction Arrhythmic Syndrome.1 passage
• The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context.1 passage
• The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.1 passage
• The NCDR Left Atrial Appendage Occlusion Registry.1 passage
• The National Cardiovascular Data Registry Voluntary Public Reporting Program: An Interim Report From the NCDR Public Reporting Advisory Group.1 passage
• The Natural History of Severe Calcific Mitral Stenosis.1 passage
• The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.1 passage
• The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.1 passage
• The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy.1 passage
• The Radial Artery for Percutaneous Coronary Procedures or Surgery?1 passage
• The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients.1 passage
• The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.1 passage
• The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography.1 passage
• The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.1 passage
• The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.1 passage
• The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.1 passage
• The Role of Nutraceuticals in Statin Intolerant Patients.1 passage
• The SI! Program for Cardiovascular Health Promotion in Early Childhood: A Cluster-Randomized Trial.1 passage
• The Secret Life of Exosomes: What Bees Can Teach Us About Next-Generation Therapeutics.1 passage
• The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care.1 passage
• The Tobacco Endgame: Eradicating a Worsening Epidemic A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology.1 passage
• The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19.1 passage
• The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.1 passage
• The Value of Left Ventricular Relative Wall Thickness in Predicting Ventricular Arrhythmia and Related Death.1 passage
• The Wearable Cardioverter-Defibrillator in Newly Diagnosed Cardiomyopathy: Treatment on the Basis of Perceived Risk.1 passage
• The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care.1 passage
• The cardiovascular in-training examination: development, implementation, results, and future directions.1 passage
• The effect of cardiorespiratory fitness on age-related lipids and lipoproteins.1 passage
• The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.1 passage
• The pathophysiological role of interstitial sodium in heart failure.1 passage
• The risk for type B aortic dissection in Marfan syndrome.1 passage
• The role of the clinical pharmacist in the care of patients with cardiovascular disease.1 passage
• The unnatural history of the ventricular septal defect: outcome up to 40 years after surgical closure.1 passage
• Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.1 passage
• Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.1 passage
• Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review.1 passage
• Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.1 passage
• Threshold of Pulmonary Hypertension Associated With Increased Mortality.1 passage
• Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.1 passage
• Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.1 passage
• Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.1 passage
• Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week.1 passage
• Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.1 passage
• Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.1 passage
• Thyroid Hormones and Cardiovascular Function and Diseases.1 passage
• Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.1 passage
• Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.1 passage
• Ticagrelor With or Without Aspirin After Complex PCI.1 passage
• Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.1 passage
• Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.1 passage
• Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.1 passage
• Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.1 passage
• Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.1 passage
• Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk.1 passage
• Time to Change Our Focus: Defining, Promoting, and Impacting Cardiovascular Population Health.1 passage
• Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF: Warfarin Versus NOACs Versus LAA Closure.1 passage
• Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.1 passage
• Timing of Oral P2Y1 passage
• Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.1 passage
• Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.1 passage
• Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial.1 passage
• Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms.1 passage
• Training for a First-Time Marathon Reverses Age-Related Aortic Stiffening.1 passage
• Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women.1 passage
• Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.1 passage
• Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.1 passage
• Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States and Europe.1 passage
• Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry.1 passage
• Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure.1 passage
• Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.1 passage
• Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Prosthesis: The PORTICO-I Trial 1-Year Outcomes.1 passage
• Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.1 passage
• Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.1 passage
• Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry.1 passage
• Transcatheter Aortic Valve Replacement in Women: Confirming Translational Science or More Confounded Clinical Research?1 passage
• Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.1 passage
• Transcatheter Aortic Valve Replacement of Failed Surgically Implanted Bioprostheses: The STS/ACC Registry.1 passage
• Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications.1 passage
• Transcatheter Bariatric Embolotherapy for Weight Reduction in Obesity.1 passage
• Transcatheter Correction of Superior Sinus Venosus Atrial Septal Defects as an Alternative to Surgical Treatment.1 passage
• Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.1 passage
• Transcatheter Electrosurgery: JACC State-of-the-Art Review.1 passage
• Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week.1 passage
• Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.1 passage
• Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial.1 passage
• Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges.1 passage
• Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.1 passage
• Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload.1 passage
• Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis.1 passage
• Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses.1 passage
• Transcatheter Therapies for Treating Tricuspid Regurgitation.1 passage
• Transcatheter Therapies for the Treatment of Valvular and Paravalvular Regurgitation in Acquired and Congenital Valvular Heart Disease.1 passage
• Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions.1 passage
• Transcatheter Valve Replacement in Asia Pacific: Current Practice and Perspectives.1 passage
• Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement.1 passage
• Transcatheter Valve-in-Valve and Valve-in-Ring for Treating Aortic and Mitral Surgical Prosthetic Dysfunction.1 passage
• Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation.1 passage
• Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.1 passage
• Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis.1 passage
• Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.1 passage
• Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease.1 passage
• Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison.1 passage
• Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device.1 passage
• Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation.1 passage
• Transesophageal Echocardiography in Patients Undergoing Coronary Artery Bypass Graft Surgery.1 passage
• Transition From Temporary to Durable Circulatory Support Systems.1 passage
• Transition Intervention for Adolescents With Congenital Heart Disease.1 passage
• Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction.1 passage
• Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.1 passage
• Translational Perspective on Epigenetics in Cardiovascular Disease.1 passage
• Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction.1 passage
• Transposition of the Great Arteries in the Developing World: Surgery and Outcomes.1 passage
• Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.1 passage
• Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.1 passage
• Transvalvular Flow Rate Determines Prognostic Value of Aortic Valve Area in Aortic Stenosis.1 passage
• Transvalvular Flow, Sex, and Survival After Valve Replacement Surgery in Patients With Severe Aortic Stenosis.1 passage
• Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.1 passage
• Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System.1 passage
• Treatment of Venous Thromboembolism With New Anticoagulant Agents.1 passage
• Trending Cardiovascular Nutrition Controversies.1 passage
• Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.1 passage
• Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure.1 passage
• Trends in Long-Term Mortality After Congenital Heart Surgery.1 passage
• Trends in Survival After In-Hospital Cardiac Arrest During Nights and Weekends.1 passage
• Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States.1 passage
• Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC Review Topic of the Week.1 passage
• Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries.1 passage
• Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.1 passage
• Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.1 passage
• Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system.1 passage
• Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.1 passage
• Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.1 passage
• Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.1 passage
• Tricuspid Intervention Following Pulmonary Valve Replacement in Adults With Congenital Heart Disease.1 passage
• Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.1 passage
• Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.1 passage
• Triglycerides and Residual Atherosclerotic Risk.1 passage
• Troponin Testing for Clinicians.1 passage
• Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction.1 passage
• Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.1 passage
• Type 2 Myocardial Infarction: JACC Review Topic of the Week.1 passage
• Type A Aortic Dissection-Experience Over 5 Decades: JACC Historical Breakthroughs in Perspective.1 passage
• Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.1 passage
• U.S. Hospital Use of Echocardiography: Insights From the Nationwide Inpatient Sample.1 passage
• Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study.1 passage
• Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.1 passage
• Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.1 passage
• Understanding Social Media: Opportunities for Cardiovascular Medicine.1 passage
• Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease.1 passage
• Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.1 passage
• Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.1 passage
• United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8.1 passage
• Universal Screening for Familial Hypercholesterolemia in Children.1 passage
• Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management.1 passage
• Unraveling Vascular Inflammation: From Immunology to Imaging.1 passage
• Upright Cheyne-Stokes Respiration in Patients With Heart Failure.1 passage
• Urinary Dickkopf-3 and Contrast-Associated Kidney Damage.1 passage
• Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.1 passage
• Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery.1 passage
• Use of Cardiac Magnetic Resonance Imaging in Assessing Mitral Regurgitation: Current Evidence.1 passage
• Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease.1 passage
• Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.1 passage
• Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.1 passage
• Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review.1 passage
• Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.1 passage
• Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.1 passage
• Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all.1 passage
• Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies.1 passage
• Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.1 passage
• Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome.1 passage
• Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.1 passage
• Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease.1 passage
• Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome: Opportunities for Improvement.1 passage
• VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.1 passage
• Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial.1 passage
• Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.1 passage
• Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.1 passage
• Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.1 passage
• Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.1 passage
• Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.1 passage
• Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From Wall Shear Stress Mapping.1 passage
• Valve-Sparing Root Replacement Compared With Composite Valve Graft Procedures in Patients With Aortic Root Dilation.1 passage
• Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.1 passage
• Valvular Heart Disease in Patients ≥80 Years of Age.1 passage
• Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9.1 passage
• Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure.1 passage
• Variation in Use of Pediatric Cardiology Subspecialty Care: A Total Population Study in California, 1983 to 2011.1 passage
• Vasa Vasorum Restructuring in Human Atherosclerotic Plaque Vulnerability: A Clinical Optical Coherence Tomography Study.1 passage
• Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.1 passage
• Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study.1 passage
• Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.1 passage
• Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.1 passage
• Vascular Teams in Peripheral Vascular Disease.1 passage
• Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.1 passage
• Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.1 passage
• Venoarterial ECMO for Adults: JACC Scientific Expert Panel.1 passage
• Venous Thromboembolism Associated With Pregnancy: JACC Focus Seminar.1 passage
• Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.1 passage
• Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients.1 passage
• Ventricular Assist Device in Acute Myocardial Infarction.1 passage
• Ventricular Ectopy as a Predictor of Heart Failure and Death.1 passage
• Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.1 passage
• Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.1 passage
• Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.1 passage
• Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.1 passage
• Vitamin D and Cardiovascular Disease: Controversy Unresolved.1 passage
• Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar.1 passage
• Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S.1 passage
• Wearable Devices for Ambulatory Cardiac Monitoring: JACC State-of-the-Art Review.1 passage
• What to Expect From the Evolving Field of Geriatric Cardiology.1 passage
• When an Increase in Central Systolic Pressure Overrides the Benefits of Heart Rate Lowering.1 passage
• Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.1 passage
• Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.1 passage
• Work Activities and Compensation of Male and Female Cardiologists.1 passage
• Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.1 passage
• Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial.1 passage
• Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.1 passage
• sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.1 passage
• von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.1 passage
• β1 passage
• β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.1 passage